Adult Medicine Ambulatory Care Cardiology Central Nervous System Clinical Administration Critical Care Drug Information Education and Training

Emergency Medicine Endocrine and Metabolism Geriatrics GI/Liver/Nutrition Global Health Hematology/Oncology HIV Immunology/Transplantation

Infectious Diseases Nephrology Pain and Palliative Care Pediatrics Perioperative Care Pharmaceutical Industry PK/PD/PG Women’s Health

Introduction

The Adult Medicine PRN is one of the largest and most diverse PRNs, encompassing pharmacists who practice in inpatient and outpatient settings, academia, and the pharmaceutical industry. The Adult Medicine PRN consists of practitioners, residents, and students who share an interest in shaping the practice of adult medicine through research and practice.

The 2015 ACCP Annual Meeting was well represented by the Adult Medicine PRN, with 67 attendees at the business meeting. The Adult Medicine PRN Programming Committee hosted a joint focus session with the Ambulatory Care PRN on “Transitions of Care Management: Best Practices,” which was well attended and successful. The committee appreciates the efforts of the speakers: Zachary Lane Cox, Pharm.D., BCPS, and Julianna L. Burton, Pharm.D., BCPS.

Our members are very active within the PRN and ACCP, especially with working on one of our many PRN committees. We appreciate all of their hard work and their accomplishments. The Archives Committee has been revising online content for our members. The Training/Travel and Nominations Committee worked on reviewing applications and giving awards to our members, as detailed below, at the 2015 Global Conference. The Walk-Rounds Committee reviewed 93 posters at the 2015 Global Conference. The Newsletter Committee has worked on creating the biannual newsletter for our members. Our Programming Committee has been developing content for the upcoming 2016 ACCP Annual Meeting. The newly created Research Committee has been developing a research project in conjunction with the ACCP Research Institute (RI). This is one of the first collaborations between a PRN and the RI, and together, they are currently working to obtain IRB approval and creating the electronic platform for this survey study. We look forward to seeing the results from this research project and to establishing future research partnerships with the ACCP RI.

 

Promotions

• Donald Moore: Oncology Pharmacy Manager at SoutheastHEALTH Cancer Center in Cape Girardeau, Missouri.
• Larry Segars: Associated Dean for the College of Biomedical Sciences graduate program at Kansas City University of Medicine and Biosciences (KCU) in Kansas City, Missouri.
• Jon P. Wietholter: Clinical Associate Professor at West Virginia University.

 

Awards

• Eunice Boo: 2015 Adult Medicine ACCP PRN Resident Travel Award.
• Jennifer Brown: 2015 Adult Medicine ACCP PRN Student Travel Award.
• Craig D. Cox: Texas Tech University Health Sciences Center Chancellor’s Council Distinguished Teaching Award.
• Leigh Anne Hylton Gravatt: 2015 Virginia Society of Health-System Pharmacy Clinical Pharmacy Practice Achievement Award.
• Antoine Jenkins: 2015 Adult Medicine ACCP PRN Practitioner Registration Award.
• Rima Mohammed: 2015 Research Institute Mentored Research Investigator Training (MeRIT) Scholarship.
• Ifeanyi Onor: 2015 Xavier University of Louisiana College of Pharmacy Preceptor of the Year Award.
• Charles F. Seifert: Several awards including the 2015 TTUHSC President’s Excellence in Team Teaching Award, the 2015 TTUHSC School of Pharmacy P3 Teacher of the Year by the Class of 2016, and the 2015 ACCP Adult Medicine PRN Paper of the Year Award.
• Mate M. Soric: 2015 ASHP Best Practices Award.
• Linda Spooner: 2015 Adult Medicine ACCP PRN Mentoring Award.
• Jennifer Austin Szwak: Residency Advancement Award.
• Jon P. Wieholter: Faculty Inductee from the Academy of Excellence in Teaching and Learning: Faculty.

 

Grants

• Sally Arif: Scholarship of Teaching and Learning (SoTL) grant from the MWU Center for Teaching Excellence. Funding: $2600.
• Ifeanyi Onor: Intramural Grant from the Center for Undergraduate Research Title II Grant. Amount funded: $2500.
• Jon P. Wietholter: “Interprofessional Collaboration for Vulnerable Acute Care Patients: An Academic-Service Partnership.” U.S. Department of Health and Human Services Health Resources and Services Administration (HRSA) for the project. Funding: $1,394,069 over 3 years.

 

Publications

• Anderson SL, Trujillo JT. Lixisenatide in type 2 diabetes: latest evidence and clinical usefulness. Ther Adv Chronic Dis 2016;7:4-17.
• Rhyne D, Anderson SL. Suvorexant in insomnia: efficacy, safety and place in therapy. Ther Adv Drug Saf 2015;6:189-95.
• Rhyne DN, Anderson SL, Gedde M, Borgelt LM. The effect of medical marijuana on migraine headache frequency in an adult population. Pharmacotherapy 2016. In press.
• Wobeter BR, Anderson SL, Marrs JC. Characterization of diastolic dysfunction heart failure following an acute hospitalization for heart failure in an urban, underserved population. Ther Adv Cardiovasc Dis 2015;9:267-74.
• Arif SA, Drury R, Ader P. Impact of food and drug administration hepatotoxicity warning on prescribing and monitoring of dronedarone in a tertiary teaching hospital. Int J Pharm Pract 2015;23:456-60.
• Arif SA, D’Souza J, Gil M, Gim S. Vorapaxar for reduction of thrombotic cardiovascular events in myocardial infarction and peripheral artery disease. Am J Health Syst Pharm 2015;72:1615-22.
• Plakogiannis R, Arif SA. Women versus men: is there equal benefit and safety from statins? Curr Atheroscler Rep 2016;18:6.
• Austin JH, Mieure KD, Weber LM, McCarthy BC. National characteristics of residency program interview processes. AJHP 2015;72:1085-6.
• McCarthy BC, McConeghy K, Austin JH. Remeasuring job satisfaction among pharmacy residents. AJHP 2015;72:997-9.
• Brunetti L, Kagan L, Forrester G, Aleksunes LM, Buyske S, Nahass RG. Cefoxitin plasma and subcutaneous adipose tissue concentration in patients undergoing sleeve gastrectomy. Clin Ther 2015 Dec 11. [Epub ahead of print]
• Brunetti L, Poiani G, Dhanaliwala F, Popitti K, Suh DC. Clinical outcomes and treatment cost comparison of levalbuterol versus albuterol in hospitalized adults with chronic obstructive pulmonary disease or asthma. Am J Health Syst Pharm 2015;72:1026-35.
• Brunetti L, Poustchi S, Cunningham D, Toscani M, Nguyen J, Lim J, Ding Y, Nahass R. Clinical and cost impact of empiric extended infusion piperacillin-tazobactam in a community medical center. Ann Pharmacother 2015;49:754-60.
• Bridges K, Pereira-da-Silva L, Tou JC, Ziegler J, Brunetti L. Bone metabolism in very preterm infants receiving parenteral nutrition: do intravenous lipid emulsions have an impact? Nutr Rev 2015;12:823-36.
• Srikonda A, Rule B, Toascani M, Adams CD, Brunetti L. Selecting a target specific anticoagulant in the geriatric population. J Clin Outcome Manage 2015;22:550-64.
• Davis K, Morrison C. Ticagrelor for neurointerventional procedures; a case series. Abstract 100. Presented at: Neurocritical Care Society Annual Meeting; October 2015; Phoenix, AZ.
• Davis KA, Miyares MA, Dietrich E. Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: a review of the evidence. Am J Health Syst Pharm 2015;72:1623-9.
• Flurie RW, Brophy DF. New medications to treat hyperkalemia. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey L, eds. Updates: Pharmacotherapy: A Pathophysiologic Approach, 9th ed. New York: McGraw-Hill, 2014. http://accesspharmacy.mhmedical.com/updatesContent.aspx?bookid=536&Sectionid=98653266.
• Flurie RW, Gonzales JP, Tata AL, Millstein LS, Gulati M. Hospital delirium treatment: Continuation of antipsychotic therapy from the intensive care unit to discharge. Am J Health Syst Pharm 2015;72(23 suppl 3):S133-9.
• Fulco PP. Being an acidic part-time pharmacist. Am J Health Syst Pharm 2015;72:604-5.
• Fulco PP. HIV-positive-to-HIV-positive kidney transplantation. N Engl J Med 2015;372:2069-70.
• Good BL, Gomes DC, Fulco PP. An unexpected interaction between warfarin and cobicistat-boosted elvitegravir. AIDS 2015;29:985-6.
• Smith K, Gomes D, Nixon D, Fulco PP. The use of unboosted darunavir in the setting of ritonavir intolerance: three case reports. Int J Clin Pharmacol Ther 2016;54:52-7.
• Donohoe KL, Dane KE, Varghese D, Hylton Gravatt LA. Evaluation of student-led journal clubs. Curr Pharm Teach Learn. In press.
• Knauss M, Bonner CL, Patka J, Abraham P. Evaluation of pharmacy resident alertness in an overnight on-call program. Am J Health Syst Pharm 2015;72:1215-20.
• Murray TS, Rice TW, Wheeler AP, et al. Medication desensitization: characterization of outcomes and risk factors for reactions. Ann Pharmacother. Pre-published January 18, 2016.
• Stirling DL, Onor IO, Sarpong DF, Rapp KI, Crawford LD. Prescribing patterns of metformin in high-risk prediabetic patients. J La State Med Soc 2015;167:257-63.
• Boyle JA, Soric MM. Impact of tranexamic acid in total knee and hip replacement. J Pharm Pract 2015. [Epub ahead of print]
• Seifert CF, Brown AT. IDSA or ACG guidelines for treatment for Clostridium difficile infection: which one to follow? The reply [letter]. Am J Med 2015;128:e19.
• Seifert CF, Brown AT. Proton pump inhibition may promote Clostridium difficile recurrences. The reply [letter]. Am J Med 2015;128:e15.
• Hong MT, Monye LC, Seifert CF. Acid suppressive therapy for stress ulcer prophylaxis in non-critically ill patients. Ann Pharmacother 2015;49:1004-8.
• Hong MT, Seifert CF. Clinical impact of discordant prescribing of fluoroquinolones and alternative treatment in E. coli pyelonephritis. J Pharm Pract 2015.
• Robles J, Pinal DI, Seifert CF. Hospitalist impact in antibiotic selection in pediatric community-acquired Staphylococcus aureus skin infection. Pediatr Ther 2015;5:2.
• Wagner LA, Tata AL, Fink JC. Patient safety issues in CKD: core curriculum 2015. Am J Kidney Dis 2015;66:156-69.
• Thurber KM, Dierkhising RA, Reiland SA, Pearson KK, Smith SA, O’Meara JG. Mealtime insulin dosing by carbohydrate counting in hospitalized cardiology patients: a retrospective cohort study. Diabetes Technol Ther 2016;18:15-21.
• Coetzee R, Wietholter JP, Schwinghammer TL. International APPE rotations: journey to sustainable clinical pharmacy services. Curr Pharm Teach Learn 2015;7:726-7.
• Cherry LN, Yunker NS, Lambert ER, Vaughan D, Lowe DK. Vedolizumab: an α4β7 integrin antagonist for ulcerative colitis and Crohn’s disease. Ther Adv Chronic Dis 2015;6:224-33.

 

Presentations

• Davis K, Morrison C. Ticagrelor for neurointerventional procedures; a case series. Abstract 100. Presented at: Neurocritical Care Society Annual Meeting; October 2015; Phoenix, AZ.

 

New ACCP Fellows

• Eli N. Deal
• Michelle L. Hilaire
• Diane W. May

 

Other Notable Achievements

• Melanie Michael: ACCP Teaching and Learning Certificate Program graduate.
• Luigi Brunetti: Inducted into the Rutgers Biomedical and Health Sciences Master Educator’s Guild.

 

Promotions

• Mary Amato: Professor of Pharmacy Practice, MCPHS University, Boston, MA
• Mary Amato: Director of the MS in Clinical Research Program, MCPHS University.
• Elizabeth A. Stone: Promotion from Clinical Pharmacist (level II) to CDTM Pharmacist (level III).

 

Awards

• Alka Bhalla: Collaborative Service Award, Ontario Pharmacists Association.
• Dave Dixon: Outstanding Contribution in Reviewing – Journal of Clinical Lipidology.
• Dave Dixon: Appointed to Cardiovascular Team Section Editorial Board for ACC.org.
• Shannon Reidt, Kristin Janke, Keri Hager, and James Beattie: American Association of Colleges of Pharmacy Innovations in Teaching Award for “When Drug Literature Evaluation Isn’t Enough: Implementation of a Longitudinal Evidence-Based Medicine (EBM) Sequence with a First-Year Milestone EBM Assessment.”
• Mate Soric: ASHP Best Practices Award 2015.

 

Grants

• Dave Dixon: “Primary Care Training Collaborative Educational Program”: Awarded by the Martin Health System Foundation. Award amount: $100,000. (Co-P)

 

Publications

• Her QL, Seger DL, Amato MG, Beeler PE, Dalleur O, Slight SP, Dykes PC, Bates DW. Development of an algorithm to assess appropriateness of override of non-formulary medication alerts in a computerized provider order entry system. Am J Health Syst Pharm 2016;73:e34-45.
• Slight SP, Eguale T, Amato MG, Seger AC, Whitney DL, Bates DW, Schiff GD. The vulnerabilities of computerized physician order entry systems: a qualitative study. J Am Med Inform Assoc 2015.
• Bishop S, Stewart K, Dixon D, Sicat B, Wolver S. Interprofessional Team-Based Learning Series: Obesity Module. MedEdPORTAL Publications. 2015. https://www.mededportal.org/publication/10125.
• Carbone S, Buckley L, Trankle C, Canada J, Dixon D, Van Tassell B, Buzzetti R, Abbate A. Obesity and heart failure: can nutrition status explain the paradoxical relationship? EC Cardiol 2015;2:94-8.
• Dixon DL. Taking medications (module 4). In: Miller D, ed. Diabetes Education Curriculum: A Guide to Successful Self-Management, 2nd ed. Chicago: American Association of Diabetes Educators, 2015.
• Dixon DL, Abbate A. Potassium levels in acute myocardial infarction: definitely worth paying attention to. Eur Heart J Cardiovasc Pharmacother 2015;1:252-3.
• Sperling LS, Mechanick JI, Neeland IJ, Herrick CJ, Despres JP, Ndumele CE, Vijayaraghavan K, Handlesman Y, Puckerin GA, Araneta MR, Blum QK, Collins KK, Cook S, Dhurandhar NV, Dixon DL, Egan BM, Ferdinand DP, Herman LM, Hessen SE, Jacobson TA, Pate RR, Ratner RE, Brinton EA, Forker AD, Ritzenthaler LL, Grundy S. The CardioMetabolic Health Alliance: working toward a new care model for the metabolic syndrome. J Am Coll Cardiol. 2015;66:1050-67.
• Canada JM, Fronk DT, Freeman L, Carbone S, Erdle CO, Abouzaki NA, Mechior RD, Thomas CS, Christopher S, Turlington JS, Trankle CR, Thurber CJ, Evans RK, Dixon DL, Van Tassell BW, Arena R, Abbage A. Usefulness of C reactive protein plasma levels to predict exercise tolerance in patients with chronic systolic heart failure. Am J Cardiol 2016;117:116-20.
• Goldman JD, White J. New insulin glargine 300 U/ml for the treatment of type 1 and type 2 diabetes mellitus. Ann Pharmacother 2015;49:1153-61.
• Patel D, Charkoudian M, Goldman JD, Couris R. Focus on hypoglycemia: patient education, disease management and prevention. Nutr Today 2015;50:277-81.
• Hager KD, Gosser RA. Retrospective analysis of billing at a stand-alone medication therapy management clinic. Am J Health Syst Pharm 2015;73:77-81.
• Hill LG. Compounded vancomycin solution for Clostridium difficile infection. Evid Based Pract 2015;18:2.
• Hill LG. Effect of time of day on lipoprotein measurement. Evid Based Pract 2015;18:11.
• Hutchison RW Jr. Transforming pain management and the role of the clinical pharmacist. Hosp Pharm 2016;51:6-8.
• Ip EJ, Yadao MA, Shah BM, Lau B. Infectious disease, injection practices, and risky sexual behavior among anabolic steroid users. AIDS Care 2016;28:294-9.
• Lindfelt TA, Ip EJ, Barnett MJ. Career satisfaction, work-life balance and stress among United States pharmacy school faculty: snapshot from a comprehensive survey. Am J Health Syst Pharm 2015;72:1573-8.
• Perry PJ, Fredriksen K, Chew S, Ip EJ, Lopes I, Doroudgar S, Thomas K. The effects of dextromethorphan on driving performance and the standardized field sobriety test. J Forensic Sci 2015;60:1258-62.
• Minze MG, Koffarnus RL, Bailey TA, Diec S, Edwards KL. Sodium-glucose co-transporter 2 inhibitors: evidence and place in therapy. Expert Rev Endocrinol Metab 2015;10:645-61.
• Minze MG, Kwee Y, Hall RG III. Low-molecular-weight heparin prophylaxis dosing: is weight an issue? J Pharm Technol. [Published online November 18, 2015]
• Rudd KM, Winans ARM, Panneerselvam N. Possible rivaroxaban failure during the postpartum period. Pharmacotherapy 2015;35:e164-e168.
• Boyle JA, Soric MM. Impact of tranexamic acid in total knee and hip replacement. J Pharm Pract 2015. [Epub ahead of print]
• Winans ARM, Pawasauskas J, Sera L. Symptom management overview: opioid-induced constipation. J Hematol Oncol Pharm 2015. [Epub ahead of print]

 

New ACCP Fellows

• Mary Amato
• Michelle Hilaire

 

Other Notable Achievements

• Amanda Winans: Certified Anticoagulation Provider (CACP) recognition.

 

Promotions

• Craig J. Beavers: Clinical Pharmacy Coordinator, Cardiology at UK HealthCare.
• James Hollands: Vice Chair of Clinical Pharmacy at Philadelphia College of Pharmacy.
• Benjamin Van Tassell: Associate Professor with Tenure (VCU School of Pharmacy).
• Benjamin Van Tassell: Vice Chair for Research (VCU School of Pharmacy, Department of Pharmacotherapy & Outcomes Science).

 

Awards

• Toby Trujillo: Best Paper – Second Runner-up at the 2015 ACCP Global Conference on Clinical Pharmacy for “Evaluation of the Safety and Tolerability of Target Specific Oral Anticoagulants at a Large University Setting.”
• Benjamin Van Tassell: Blick Scholar (VCU).
• Benjamin Van Tassell: Teaching Excellence Award (VCU School of Pharmacy).

 

Grants

• Dave L. Dixon: $100,000 grant from Martin Health System Foundation for “Primary Care Training Collaboration Education Program.” (Co-P)

 

Publications

• Baker WL, Bennetts M, Coleman CI, Cappelleri JC. Appraising evidence. In: Biondi-Zoccai G, ed. Umbrella Reviews – Evidence Synthesis with Overviews of Reviews and Meta-epidemiologic Studies. Springer, 2016.
• Baker WL, Saulsberry WJ, Elliot K, Parker MW. Cardiac magnetic resonance imaging-confirmed mesalamine-induced myocarditis. BMJ Case Rep 2015 Sep 4.
• Linder KE, Baker WL, Rochon C, May ST, Sheiner PA, Martin ST. Evaluation of new-onset diabetes post-liver transplantation: assessment of insulin administration as a risk factor. Ann Pharmacother. In press.
• Beavers CJ, Carris NW, Ruf KM. Clopidogrel hypersensitivity: consideration for interventionist. Drugs 2015;75:999-1007.
• Beavers CJ, Heron PA, Smyth SS, Bain JA, Macaulay TE. Obesity and antiplatelets – does one size fit all? Thromb Res 2015;136:712-6.
• Pahs LA, Schuler P, Beavers CJ. The impact of a standardized novel oral anticoagulant reversal protocol: a multicenter evaluation. Crit Pathw Cardiol 2015;14:53-61.
• Buckley L, Carter D, Matta L, Cheng JWM, Stevens CA, Belenkiy R, Young MA, Burpee L, Weiffenbach C, Smallwood J, Stevenson LW, Desai AS. Intravenous diuretic therapy for the management of heart failure and volume overload in a multidisciplinary outpatient unit. J Am Coll Cardiol 2016;4:1-8.
• Buckley L, Reardon DP, Camp PC, Weinhouse GL, Silver DA, Couper GS, Connors JM. Aminocaproic acid for the management of bleeding in patients on extracorporeal membrane oxygenation: four adult case reports and a review of the literature. Heart Lung. In press.
• Fanikos J, Buckley L, Aldemerdash A, Terry K, Piazza G, Connors J, Goldhaber S. Legislative, regulatory and policy updates with anticoagulant use. J Thromb Thrombolysis 2015;39:273-87.
• Hedges A, Coons JC, Saul M, Smith RE. Clinical effectiveness and safety outcomes associated with prothrombin complex concentrates. J Thromb Thrombolysis 2015 Dec 19.
• Verlinden NV, Coons JC. Disopyramide for hypertrophic cardiomyopathy: a pragmatic reappraisal of an old drug. Pharmacotherapy 2015;35:1164-72.

• Bishop S, Stewart K, Dixon D, Sicat B, Wolver S. Interprofessional Team-Based Learning Series: Obesity Module. MedEdPORTAL Publications. 2015. Available at https://www.mededportal.org/publication/10125.
• Carbone S, Buckley L, Trankle C, Canada J, Dixon D, Van Tassell B, Buzzetti R, Abbate A. Obesity and heart failure: can nutrition status explain the relationship? EC Cardiology 2015;2:94-8.
• Dixon DL. Taking medications (module 4). In: Miller D, ed. Diabetes Education Curriculum: A Guide to Successful Self-Management, 2nd ed. Chicago: American Association of Diabetes Educators, 2015.
• Dixon DL, Abbate A. Potassium levels in acute myocardial infarction: definitely worth paying attention to. Eur Heart J Cardiovasc Pharmacother 2015;1:252-3.
• Canada JM, Fronk DT, Freeman L, Carbone S, Erdle CO, Abouzaki NA, Mechior RD,Thomas CS, Christopher S, Turlington JS, Trankle CR, Thurber CJ, Evans RK, Dixon DL, Van Tassell BW, Arena R, Abbage A. Usefulness of C reactive protein plasma levels to predict exercise tolerance in patients with chronic systolic heart failure. Am J Cardiol 2016;117:116-20.
• Sperling LS, Mechanick JI, Neeland IJ, Herrick CJ, Despres JP, Ndumele CE, Vijayaraghavan K, Handlesman Y, Puckerin GA, Araneta MR, Blum QK, Collins KK, Cook S, Dhurandhar NV, Dixon DL, Egan BM, Ferdinand DP, Herman LM, Hessen SE, Jacobson TA, Pate RR, Ratner RE, Brinton EA, Forker AD, Ritzenthaler LL, Grundy S. The CardioMetabolic Health Alliance: working toward a new care model for the metabolic syndrome. J Am Coll Cardiol 2015;66:1050-67.
• Dunn SP, Birtcher KK, Beavers CJ, Baker WL, Brouse SD, Page RL, Bittner V, Walsh MN. The role of the clinical pharmacist in the care of patients with cardiovascular disease. J Am Coll Cardiol 2015;66:2129-39.
• Hangian S, DiDomenico RJ. Emerging therapies for acute and chronic heart failure: hope or hype? J Pharm Pract 2016;29:46-57.
• Lee CR, Zeldin DC. Clinical implications of basic research: resolving infectious inflammation by targeting the host response. N Engl J Med 2015;373:2183-5.
• Oni-Orisan A, Edin ML, Lee JA, Wells MA, Christensen ES, Vendrov KC, Lih FB, Tomer KB, Bai X, Taylor, JM, Stouffer GA, Zeldin DC, Lee CR. Cytochrome P450-derived epoxyeicosatrienoic acids and coronary artery disease in humans: a targeted metabolomics study. J Lipid Res 2016;57:109-19.
• Macaulay TE, Covell MB, Pogue KT. An update on the management of pulmonary arterial hypertension and the pharmacist’s role. J Pharm Pract 2016;29:67-76.
• McConnell KJ, Baker WL. Blood pressure management. In: Pharmacotherapy Self-Assessment Program 2016, Book 1. American College of Clinical Pharmacy, 2016:7-30.
• Oliphant CS, Trevarrow BJ, Dobesh PP. Clopidogrel response variability: review of the literature and practical considerations. J Pharm Pract 2016;29:26-34.
• Parker MH, Sanoski CA. Clinical pearls in using antiarrhythmic drugs in the outpatient setting. J Pharm Pract 2016;29:77-86.
• Phillips E, Saseen JJ. Current controversies with recent cholesterol treatment guidelines. J Pharm Pract 2016;29:15-25.
• Hart C, Price C, Graziose G, Grey J. Case study: using pharmacy technicians to improve the accuracy of medication histories collected in the ED. Available at www.ashpmedia.org/ppmi/docs/casestudy_Hart.pdf.
• Hart C, Price C, Graziose G, Grey J. A program using pharmacy technicians to collect medication histories in the emergency department. P T 2015;40:56-61.
• Price CA. Drug monographs. In: Abramovitz J, Schilling McCann JA. Nursing 2016 Drug Handbook, 36th ed. Philadelphia: Wolters Kluwer, 2016.
• Ripley TL, Baumert M. Controversies among the hypertension guidelines. J Pharm Pract 2016;29:5-14.
• Schwier NC. Pharmacotherapeutic considerations for using colchicine to treat idiopathic pericarditis in the United States. Am J Cardiovasc Drugs 2015;15:295-306.
• Schwier NC. Pharmacotherapeutic considerations for the treatment of thyrotoxic pericarditis. Int J Cardiol 2015;201:182-3.
• Schwier NC, Coons JC, Rao SK. Pharmacotherapy update of acute idiopathic pericarditis. Pharmacotherapy 2015;35:99-111.
• Shapiro NL, Bhatt SH. Critical review and update on the treatment of acute and chronic pulmonary embolism. J Pharm Pract 2016;29:35-45.
• Teeter C, Jennings DL. Device-related thrombosis in continuous-flow left ventricular assist device support. J Pharm Pract 2016;29:56-68.
• Gomez-Arroyo J, Sakagami M, Syed AA, Farkas L, Van Tassell B, Kraskauskas D, Mizuno S, Abbate A, Bogaard HJ, Byron PR, Voelkel NF. Iloprost reverses established fibrosis in experimental right ventricular failure. Eur Respir J 2015;45:449-62.
• Huynh K, Van Tassell B, Chow SL. Predicting therapeutic response in patients with heart failure: the story of C-reactive protein. Expert Rev Cardiovasc Ther 2015;13:153-61.
• Van Tassell BW, Raleigh JM, Abbate A. Targeting interleukin-1 in heart failure and inflammatory heart disease. Curr Heart Fail Rep 2015;12:33-41.
• Abbate A, Arena R, Abouzaki N, Van Tassell BW, Canada J, Shah K, Biondi-Zoccai G, Voelkel NF. Heart failure with preserved ejection fraction: refocusing on diastole. Int J Cardiol 2015;179:430-40.
• Abbate A, Kontos MC, Abouzaki NA, Melchior RD, Thomas C, Van Tassell BW, Oddi C, Carbone S, Trankle CR, Roberts CS, Mueller GH, Gambill ML, Christopher S, Markley R, Vetrovec GW, Dinarello CA, Biondi-Zoccai G. Comparative safety of interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction (from the VCU-ART and VCU-ART2 pilot studies). Am J Cardiol 2015;115:288-92.
• Abbate A, Van Tassell BW, Canada JM, Dixon DL, Arena RA, Biondi-Zoccai G. Pharmacologic and surgical interventions to improve functional capacity in heart failure. Heart Fail Clin 2015;11:117-24.
• Abbate A, Van Tassell BW, Christopher S, Abouzaki NA, Sonnino C, Oddi C, Carbone S, Melchior RD, Gambill ML, Roberts CS, Kontos MC, Peberdy MA, Toldo S, Vetrovec GW, Biondi-Zoccai G, Dinarello CA. Effects of Prolastin C (plasma-derived alpha-1 antitrypsin) on the acute inflammatory response in patients with ST-segment elevation myocardial infarction (from the VCU-alpha 1-RT pilot study). Am J Cardiol 2015;115:8-12.
• Carbone S, Mauro AG, Mezzaroma E, Kraskauskas D, Marchetti C, Buzzetti R, Van Tassell BW, Abbate A, Toldo S. A high-sugar and high-fat diet impairs cardiac systolic and diastolic function in mice. Int J Cardiol 2015;198:66-9.
• Marchetti C, Toldo S, Chojnacki J, Mezzaroma E, Liu K, Salloum FN, Nordio A, Carbone S, Mauro AG, Das A, Zalavadia AA, Halquist MS, Federici M, Van Tassell BW, Zhang S, Abbate A. Pharmacologic inhibition of the NLRP3 inflammasome preserves cardiac function after ischemic and nonischemic injury in the mouse. J Cardiovasc Pharmacol 2015;66:1-8.
• Mezzaroma E, Mikkelsen RB, Toldo S, Mauro AG, Sharma K, Marchetti C, Alam A, Van Tassell BW, Gewirtz DA, Abbate A. Role of interleukin-1 in radiation-induced cardiomyopathy. Mol Med 2015;21:210-8.
• Regan JA, Mauro AG, Carbone S, Marchetti C, Gill R, Mezzaroma E, Valle Raleigh J, Salloum FN, Van Tassell BW, Abbate A, Toldo S. A mouse model of heart failure with preserved ejection fraction due to chronic infusion of a low subpressor dose of angiotensin II. Am J Physiol Heart Circ Physiol 2015;309:H771-8.
• Seropian IM, Sonnino C, Van Tassell BW, Biasucci LM, Abbate A. Inflammatory markers in ST-elevation acute myocardial infarction. Eur Heart J Acute Cardiovasc Care 2015 Feb 13. [Epub ahead of print]
• Toldo S, Mezzaroma E, Mauro AG, Salloum F, Van Tassell BW, Abbate A. The inflammasome in myocardial injury and cardiac remodeling. Antioxid Redox Signal 2015;22:1146-61.
• Toldo S, Mezzaroma E, McGeough MD, Peña CA, Marchetti C, Sonnino C, Van Tassell BW, Salloum FN, Voelkel NF, Hoffman HM, Abbate A. Independent roles of the priming and the triggering of the NLRP3 inflammasome in the heart. Cardiovasc Res 2015;105:203-12.

 

Presentations

• McConnell KJ. Advancing clinical pharmacy practice: updates and strategies from experts in the field focus on chronic diseases and pharmacist services. Pre-Congress Symposium held in conjunction with the GCC Pharmaceutical Congress. Sponsored by the American College of Clinical Pharmacy; October 5, 2015; Dubai, United Arab Emirates.

 

New ACCP Fellows

• William L. Baker
• Benjamin Van Tassell

 

Other Notable Achievements

• Dave Dixon: Appointed to the Cardiovascular Team Section Editorial Board for ACC.org.
• Dave Dixon: Outstanding contribution in review for the Journal of Clinical Lipidology.
• Paul P. Dobesh, Robert J. DiDomenico, and Cynthia Sanoski: Served as guest editors on the Journal of Pharmacy Practice cardiovascular issue.

 

Introduction

The CNS PRN members have been very active during the past 6 months, receiving promotions, publishing scholarly work, receiving local and national awards, and completing advanced research education. A summary of some highlights of this productivity follows.

 

Promotions

• Jack Chen: Full Professor in his secondary appointment in the Department of Neurology at the Loma Linda University School of Medicine.
• Cynthia Kirkwood: Executive Associate Dean for Academic Affairs at Virginia Commonwealth University.

 

Publications

• Alexander B, Lund BC, Bernardy NC, Christopher MLD, Friedman MJ. Early discontinuation and suboptimal dosing of prazosin: a potential missed opportunity for veterans with PTSD. J Clin Psychiatry 2015;76:e639-e644.
• Abrams TE, Lund BC, Alexander B, Bernardy NC, Friedman MJ. Geographical diffusion of prazosin across Veterans Health Administration: examination of regional variation in daily dosing and quality indicators among veterans with posttraumatic stress disorder. J Rehabil Res Dev 2015;52:619-28.
• Sciegienka A, Argo T, Cantrell M, Alexander B. Association between topiramate use and serum bicarbonate levels in a veteran population. Ann Pharmacother 2015;49:670-3.
• Bishop JR, Najjar F, Rubin LH, Guter SJ, Owley T, Mosconi MW, Jacob S, Cook EH. Escitalopram pharmacogenetics: CYP2C19 relationships with dosing and clinical outcomes in autism spectrum disorder. Pharmacogenet Genomics 2015;25:548-54.
• Brown JT, Bishop JR. Atomoxetine pharmacogenetics: associations with pharmacokinetics, treatment response and tolerability. Pharmacogenomics 2015;16:1513-20.
• Cates ME, Clark A, Woolley TW, Saunders A. Sleep quality among pharmacy students. Am J Pharm Educ 2015;79:9.
• Cates ME, Hogue MD, Woolley TW. Effects of actual participation in drug testing on the attitudes of first-year pharmacy students toward a mandatory drug testing program. Curr Pharm Teach Learn 2015;7:224-30.
• Cates ME, Jackson CW. Posttraumatic stress disorder. In: Dong BJ, Elliott DP, eds. Ambulatory Care Self-Assessment Program, 2015 Book 1. Neurologic and Psychiatric Care. Lenexa, KS: American College of Clinical Pharmacy, 2015:93-115.
• Dashtipour K, Chen JJ, Frei K, Nahab F, Tagliati M. Systematic literature review of abobotulinumtoxinA in clinical trials for blepharospasm and hemifacial spasm. Tremor Other Hyperkinet Mov (N Y). 2015;5:338.
• Dashtipour K, Chen JJ, Walker HW, Lee MY. Systematic literature review of abobotulinumtoxinA in clinical trials for lower limb spasticity. Medicine (Baltimore). 2016;95:e2468.
• Burghardt KJ, Evans SJ, Wiese KM, Ellingrod VL. An untargeted metabolomics analysis of antipsychotic use in bipolar disorder. Clin Transl Sci 2015;8:432-40.
• Burghardt KJ, Goodrich JM, Dolinoy DC, Ellingrod VL. DNA methylation, insulin resistance and second-generation antipsychotics in bipolar disorder. Epigenomics 2015;7:343-52.
• Fiedorowicz JG, Ellingrod VL, Kaplan MJ, Sen S. The development of depressive symptoms during medical internship stress predicts worsening vascular function. J Psychosom Res 2015;79:243-5.
• Flowers SA, Ellingrod VL. The microbiome in mental health: potential contribution of gut microbiota in disease and pharmacotherapy management. Pharmacotherapy 2015;35:910-6.
• Jann J, Cohen L. Editors of the textbook Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents; newly available. Other CNS PRN members who are contributing authors include Ellingrod V, Lee K, VanDenBerg C, and Kennedy K.
• Collier M, Nichols SD, Campbell J. In your dreams – a case of presumed rapid eye movement behavior disorder in the inpatient psychiatric unit. J Sleep Disord Manage. In press.
• Berg M, Privitera M, Diaz F, Dworetzky B, Elder E, Gidal B, Jian W, Krebill R, McBee N, Pollard J, Alloway R, Paige AL, Szaflarski J, Bolger P, Welty T. Equivalence among generic AEDS (EQUIGEN): single-dose study. American Epilepsy Society. 2015;Abstract 2.267. https://www.aesnet.org/meetings_events/annual_meeting_abstracts/find/Welty/0/0/0.
• Duncan W, Bottenberg M, Chase M, Chesnut R, Clarke C, Schott K, Torry R, Welty T. An industrial engineering approach to cost containment of pharmacy education. Am J Pharm Educ 2015;79:Article 31.
• Privitera MD, Welty TE, Gidal BE, Diaz FJ, Krebill R, Szarflarski JP, Dworetzky BA, Pollard JR, Eller EJ, Jiang W, Jiang X, Berg M. Generic-to-generic lamotrigine switches in people with epilepsy: a randomized, controlled trial. Lancet Neurol. In press.

 

Other Notable Achievements

• Stephanie Nichols: Serving as the Psychiatric Pharmacist for an American Academy of Family Physicians project funded by the U.S. Food and Drug Administration (FDA) under Award/Contract No. HHSF223201510130C (the “Award Agreement”) to conduct a study titled “Safe Stimulant Medication Prescribing for Adult Attention Deficit Hyperactivity Disorder (ADHD)” (the “ADHD Study”). This connection was achieved through the ACCP RI.

 

Introduction

The CADM PRN has developed a topic for the 2016 ACCP Annual Meeting and submitted a proposal focused on integrating an established performance improvement method for accelerating change in health care systems using examples such as providing medication reconciliation, granting clinical dosing authorities to pharmacists, and engaging patients in post-discharge comprehensive medication reviews. The CADM PRN has had a 14% growth in membership during the past year, a reflection of members’ increasing interest in leadership within health systems and health care organizations. The CADM PRN donated to the Research Institute Frontiers Fund and is evaluating partnership with the Leadership and Management Academy to offer financial support this year because this Academy track supports the PRN’s mission to promote leadership.

 

Promotions

• Richard J. Artymowicz: Administrative Director of the Center for Wound Healing at Cape Regional Medical Center; Cape May Court House, NJ.
• Harminder Sikand: Full Clinical Professor at the University of California, San Francisco School of Pharmacy.

 

Awards

• Harminder Sikand: Pharmacist of the Year Award, San Diego Society of Health-System Pharmacists.

 

Publications

• Poveromo L, Michalets E, Sutherland S. Midodrine for the weaning of vasopressor infusions. J Clin Pharm Ther 2016. Accepted for publication.
• Parrish RH II. Positioning a pediatric compounded non-sterile product electronic repository (pCNPeRx) within the health information technology infrastructure. Pharmacy (Special Edition – Pharmacy Paediatrics) 2016;4:Article 2 (refereed). Available at www.mdpi.com/2226-4787/4/1/2.
• Bhatt-Mehta V, MacArthur RB, Löbenberg R, Cies JJ, Cernak I, Parrish RH II. An algorithm that identifies compounded non-sterile products that can be formulated on a commercial scale or imported to promote safer medication use in children. Pharmacy (Special Issue – Pharmacy Paediatrics) Pharmacy 2015;3:284-94 (refereed). Available at www.mdpi.com/2226-4787/3/4/284.
• Gunther M, Ginther S, Chan A, Parrish RH II. Development of a surgery pharmacists community of practice in Alberta: combining technology with tacit knowledge. Pharmacotherapy 2015;35:e245 (abstract) (refereed).

 

Other

• Richard Parrish: Elected as Secretary of the Perioperative Care PRN.
• Bethany Bryant: Led an interdisciplinary team addressing inpatient delirium in a community hospital. The team was accepted to present a symposium at the upcoming annual meeting of the American Delirium Society in June 2016: Childress BC, Bryant W, Bowman S, Enoch D, Jones DN, Wilson E. A multi-disciplinary approach to addressing delirium in the acutely ill. Presented at: American Delirium Society Annual Meeting; June 2016; Nashville, TN.

 

Introduction

The Critical Care PRN Recognition Committee has been completing its charges for the year. Several members from the Critical Care PRN were nominated for ACCP offices and awards. This PRN honors its members by presenting its own awards every year. Nominations are currently open for these awards and will close in August 2016. PRN members were recognized for their achievements throughout the past year at the PRN business meeting at the 2015 Global Conference.

 

Promotions

• Alexander Flannery: PGY2 Program Director, Critical Care Pharmacy Residency.
• Leslie Hamilton: Associate Professor, University of Tennessee Health Science Center College of Pharmacy.
• Megan Rech: PGY2 Critical Care Residency Program Director.
• Pamela Smithburger: Associate Professor.
• Kristan Vollman: Co-Coordinator, PGY1 Pharmacy Residency Program.

 

Awards

• Leslie Hamilton: Most Influential Professor, University of Tennessee Health Science Center College of Pharmacy.
• Drayton Hammond: SCCM Presidential Citation, ACCP Critical Care Practice and Research Member Grant, UAMS Women’s Giving Circle Foundation Award, AAHP Research Award (second place – student section).
• Mojdeh Heavner: Pharmacist of the Year (Connecticut Society of Health-System Pharmacists).
• Juan Maldonado: Star Medical Award at Medical Division, Eli Lilly, PR.
• Rachel Park: MHS President’s Award of Excellence.
• Sid Patanwala: Drake University Alumni Achievement Award.
• Denise Rhoney: ACCP Critical Care PRN Education Award, Presidential Service Award, Neurocritical Care Society – October 2015, Presidential Citation, Neurocritical Care Society – October 2015.
• Pamela Smithburger: Lambda Kappa Sigma National Advisor of the Year.

 

Grants

• Sandy Bartlett: Husson University School of Pharmacy (HUSOP) Starter Grant.
• Denise Rhoney: “Optimizing Drug Doses to Improve Outcomes of Critically Ill Patients.” Funded (2015–2016) MCTSA005, CTSA Consortium Multi-institutional Collaborative Translational Research Pilot Grant. (PI)

 

Publications

• Terry KJ, Anger KE, Szumita PM. Prospective evaluation of inappropriate unable-to-assess CAM-ICU documentations of critically ill adult patients. J Intensive Care 2015;3:52.
• Torbic H, Szumita PM, Anger KE, Nuccio P, LaGambina S, Weinhouse G. Clinical and economic impact of formulary conversion from inhaled Flolan to inhaled Veletri for refractory hypoxemia in critically ill patients. Ann Pharmacother 2016;50:106-12.
• Hohlfelder BA, Anger KE, Szumita PM, Degrado JR. Etanercept for the treatment of transplantation-related lung injury after hematopoietic stem cell transplantation. Am J Ther 2016. In press.
• Hohlfelder B, Stashek C, Anger KE, Szumita PM. Utilization of a pharmacy clinical surveillance system for pharmacist alerting and communication at a tertiary academic medical center. J Med Syst 2016;40:24.
• Hohlfelder BA, Szumita PM, Anger KE, Stashek C. Improvement of a parenteral to enteral conversion program at a tertiary academic medical center. Am J Health Syst Pharm Res 2015;72(suppl 3):S145-9.
• Reardon DP, Anger KE, Szumita PM. The pathophysiology, assessment, and management of pain in critically ill adults. Am J Health Syst Pharm 2015;72:1531-43.
• Beavers CJ, Heron P, Smyth S, Bain J, Macaulay T. Obesity and antiplatelets – does one size fit all? Thromb Res 2015;136:712-6.
• Kido K, Wheeler M, Seratnahaei A, Bailey A, Bain JA. Rhabdomyolysis precipitated by possible interaction of ticagrelor with high-dose atorvastatin. J Am Pharm Assoc (2003). 2015;55:320-3.
• Bartlett SC. A cup of cool water. Am J Health Syst Pharm 2015;72:1496-8.
• Bartlett SC. Clinical pearl – Holy Grail of NOAC reversal agent may be in the pipeline. MSHP Bull 2015;1:3.
• Bland CM, Branan TN. Other ICU infections. In: Fish DN, ed. Critical Care Self-Assessment Program Book 1. ICU Infections. Lenexa, KS: American College of Clinical Pharmacy, 2016.
• Brophy A, Ray S. Chapter 29: corticotrophins, corticosteroids, and prostaglandins. In: Ray S, ed. Side Effects of Drugs Annual, Vol. 37. Oxford, UK: Elsevier, 2015:491-8.
• Opsha Y, Brophy A. Chapter 33: blood, blood components, plasma, and plasma products. In: Ray S, ed. Side Effects of Drugs Annual, Vol. 37. Oxford, UK: Elsevier, 2015:403-18.
• Buckley MS, Anderson C, Park AS, Barletta J, Bikin D, Wicks LM, O’Malley C, Gerkin R, Kane-Gill SL. Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients. Am J Med 2015;905-13.
• Buckley MS, Reeves BA, Barletta JF, Bikin DS. Correlation of free and total phenytoin serum concentrations in critically ill patients. Ann Pharmacotherapy 2016. [Published ahead of print]
• Smithburger PL, Buckley MS, Lat I, Culver MA, Handler SM, Kirisci L, Sokol S, Kane-Gill SL. A multicenter evaluation of off label medication use and associated adverse drug reactions in adult medical intensive care units. Crit Care Med 2015;43:1612-21.
• Dager WE, Tsu LV, Pon TK. Considerations for systemic anticoagulation in ESRD. Semin Dial 2015;28:354-62.
• Gosselin RC, Francart SJ, Hawes EM, Moll S, Dager WE, Adcock DM. Heparin-calibrated chromogenic anti-Xa activity measurements in patients receiving rivaroxaban: can this test be used to quantify drug level? Ann Pharmacother 2015;49:777-83.
• Ragucci KR, O’Bryant CL, Campbell KB, Buck ML, Dager WE, Donovan JL, Emerson K, Gubbins PO, Haight RJ, Jackevicius C, Murphy JE, Prohaska E. The need for PGY2-trained clinical pharmacy specialists. Pharmacotherapy 2014;34:e65-73.
• Flannery AH, Cook AM, Martin CM. Antimicrobial dosing in obesity. Demystifying drug dosing in obese patients. American Society of Health-System Pharmacy, 2015.
• Flannery AH, Parli SE. Medication errors in cardiopulmonary arrest and code-related situations. Am J Crit Care 2016;25:12-20.
• Flannery AH, Willey MD, Thompson-Bastin ML, Buch KP, Bensadoun ES. Eosinophilia and fever with levetiracetam: a case report. Pharmacotherapy 2015;35:e131-5.
• Foster JL, Mohorn PL, Luis AJ. Constipation-induced acute urinary retention in the intensive care unit. Am Surg 2015;81:316-8.
• Bookstaver PB, Foster JL, Lu ZK, Mann JR, Ambrose C, Grant A, Burgess S. Hepatitis B virus seroconversion rates among health sciences students in the southeastern United States. J Am Coll Health 2016;64:69-73.
• Groth CM, Aquisto NM, Khadem T. Current practices and safety of medication use during rapid sequence intubation (RSI). Crit Care Med 2015;43:A582.
• Groth CM, Dodds Ashley ES. Infection critical care I: fungal infections in the ICU. CCSAP 2016.
• Gashlin LZ, Groth CM, Wiegand TJ, Dodds Ashley ES. Comparison of alcohol withdrawal outcomes in patients treated with benzodiazepines alone versus adjunctive phenobarbital: a retrospective cohort study. Asia Pacific J Med Toxicol 2015;4:24-8.
• Hammond DA, Garner SS, Linder MA, Cousins WB, Bookstaver PB. Mentor involvement with pharmacy students pursuing post-graduate residency training. Curr Pharm Teach Learn 2016;8:18-23.
• Hammond DA, Thano E, Bohnenberger K, McAllister M, Wannenburg T, Hsu S, Gurley B, Kim R. Ventricular tachycardia precipitated by the use of diet supplement Hydroxycut® GummiesTM. Hosp Pharm 2015;50:615-8.
• Michaud CJ, Bullard HM, Harris SA, Thomas WL. Impact of quetiapine treatment on duration of hypoactive delirium in critically ill adults: a retrospective analysis. Pharmacotherapy 2015;35:731-9.
• Mo Y, Nehring F, Jung AH, Housman ST. Possible hepatotoxicity associated with daptomycin: a case report and literature review. J Pharm Pract 2016 Jan 13.
• Mo Y, Thomas MC, Karras GE Jr. Barbiturates for the treatment of alcohol withdrawal syndrome: a systematic review of clinical trials. J Crit Care 2015 Dec 8.
• Mo Y, Zimmermann AE, Thomas MC. Practice patterns and opinions on current clinical practice guidelines regarding the management of delirium in the intensive care unit. J Pharm Pract 2016 Jan 13.
• Mueller EW. Infectious diseases I. In: Abel EE, Bauer SR, Benken ST, et al. Updates in Therapeutics^®: Critical Care Pharmacy Preparatory Review Course, 2015 ed. Lenexa, KS: American College of Clinical Pharmacy, 2015:293-324.
• Mueller EW, Amato M, Bishop JR, Cavallari LH, Dupuis RE, Gregory PJ, Kanaan AO, Kiser TH, Phan H, Williams C, Yang KY. Research fellowship programs as a pathway for training independent clinical pharmacy scientists: ACCP Research Fellowship Program Review Committee Commentary. Pharmacotherapy 2015 Mar 10. [Epub ahead of print]
• Mueller EW, Fabian TC. Adjunctive intraventricular antibiotic therapy for bacterial central nervous system infections in critically ill patients with traumatic brain injury. Ann Pharmacother 2015;49:515-22.
• Droege CA, Mueller EW. Fentanyl pharmacokinetics in critically ill patients: a demonstration of mixed effects. Crit Care Med 2016;44:240-2.
• Droege ME, Van Fleet S, Mueller EW. Practical application of antibiotic pharmacodynamics and dosing principles in patients with sepsis. Crit Care Nurse. In press.
• McClellan N, Swanson JM, Magnotti LJ, Griffith TW, Wood GC, Croce MA, Boucher BA, Isemann B, Mueller EW, Narendran V, Akinbi H. Impact of early sodium supplementation on weight gain in premature infants: a randomized, blinded placebo-controlled trial. JPEN 2014. [Epub]
• Park RE, Chelemer S, Varghese J, et al. Safety and efficacy of lean body weight based heparin dosing in obese and morbidly obese patients. Chest 2015;148:1010A-1010B.
• Peters NA, Paciullo CP. Alteplase for the treatment of pulmonary embolism: a review. Adv Emerg Nurs J 2015;37:258-72.
• Quidley AM. Collateral damage: balancing the risks and benefits of antimicrobial prophylaxis. Orthopedics 2015;38:281-2.
• Quidley AM, Kaplow R. Pharmacologic support following cardiac surgery. In: Hardin SR, Kaplow R, eds. Essentials in Cardiovascular Surgery, 2nd ed. Burlington, MA: Jones & Bartlett, 2015.
• Quidley AM, LeClaire A, Frasiolas JG, Berger K, Gonzales J, Oyen L. Implementation and expansion of a national, web-based critical care pharmacy journal club. Am J Health Syst Pharm 2015;72:1260-2.
• Bookstaver PB, Quidley AM. Central nervous system in immunocompetent hosts. In: Murphy JE, Lee MW, eds. Pharmacotherapy Self-Assessment Program 2013–2015. American College of Clinical Pharmacy. 2015.
• Evans R, Quidley AM, Blake EW, Maxwell WD, Rac H, Shah PJ, Millisor VE, Lu K, Bookstaver PB. Pharmacy resident research publication rates: a national and regional comparison. Curr Pharm Teach Learn 2015;7:787-93.
• Rech MA, Bennett S, Chaney W, Sterk E. Risk factors for mortality in septic patients who received etomidate. Am J Emerg Med 2015;33:1340-3.
• Rech MA, Wittekindt L, Friedman SD, Kling K, Ubogy D. Prothrombin complex concentrate for intracerebral hemorrhage secondary to vitamin K deficiency bleeding in a 6-week-old child. J Pediatr 2015;167:1443-4.
• Czeck EE, Quinn AL, Rech MA. Opioid and common co-ingestant antidotes, drug overdoses and alcohol withdrawal: prevalence, trends and prevention. In: Morales DP, ed. ISBN: 978-1-63483-873-3. https://www.novapublishers.com/catalog/product_info.php?products_id=56133.
• Day S, Cucci M, Droege M, Erdman M, Holzhausen J, Kram B, Kram S, Pajoumand M, Parker C, Patel M, Peitz G, Poore A, Turck C, Van Berkel M, Wong A, Zomp A, Rech MA. Major publications in the critical care pharmacotherapy literature: January 2014 through December 2014. Am J Health Syst Pharm 2015;72:1974-85.
• Smithburger PL, Buckley MS, Sokol S, Culver MA, Lat I, Handler SM, Kirisci L, Kane-Gill SL. A multi-center evaluation of off label medication use and adverse drug reactions in adult medical intensive care units. Crit Care Med 2015;43:1612-21.
• Farina NM, Smithburger PL, Kane-Gill SL. Screening and management of delirium in critically ill patients. Hosp Pharm 2015;50:667-71.
• Liput SA, Kane-Gill SL, Seybert AL, Smithburger PL. Attitudes and perceptions of healthcare providers and family members towards family involvement in active patient care in the intensive care unit. Crit Care Med 2016. Accepted for publication.
• Lyons P, Nery J, Rivosecchi R, Smithburger PL, Kane-Gill SL. Fentanyl induced hyperalgesia in acute pain management. J Pain Palliat Care Pharmacother 2015;29:153-60.
• Rivosecchi R, Kane-Gill SL, Svec S, Campbell S, Smithburger PL. The implementation of a non-pharmacologic protocol to prevent intensive care delirium. Crit Care 2016;31:206-11.
• Wong A, Smithburger PL, Kane-Gill SL. Review of adjunctive dexmedetomidine in the management of acute alcohol withdrawal syndrome. Am J Drug Alcohol Abuse 2015;41:382-91.
• Vollman KE, Adams CB, Shah MN, Acquisto NM. Survey of emergency medicine pharmacy education opportunities for students and residents. Hosp Pharm 2015;50:690-9.
• Adams CB, Vollman KE, Leventhal EL, Acquisto NM. Emergent pediatric anticoagulation reversal using a 4-factor prothrombin complex concentrate. Am J Emerg Med 2015 [Epub ahead of print]
• Dickerson RN, Voss JR, Schroeppel TJ, et al. Feasibility of jejunal enteral nutrition for patients with severe duodenal injuries. Nutrition 2016;32. In press.

 

New ACCP Fellows

• Sid Patanwala

 

Other Notable Achievements

• Jonathan Bain: Organizational Affairs Committee Vice Chair, American College of Clinical Pharmacy, Adult Board Review Item Writing for MCCBRC, Society of Critical Care Medicine.
• Trisha Branan: Georgia Society of Health-System Pharmacists – Secretary.
• Mitchell Buckley: ACCP 2017 Annual Program Committee.
• William Dager: Elected Reagent – American College of Critical Care Medicine.
• Alexander Flannery: Executive Committee (New Practitioners Forum) – American Society of Health-System Pharmacists.
• Leslie Hamilton: Chair, Awards Committee, AACP Pharmacy Practice Section.
• Drayton Hammond: Secretary/Treasurer for Critical Care PRN of ACCP, President-Elect for Arkansas chapter of ACCP.
• Eric W. Mueller: Critical Care Pharmacotherapy Trials Network (CCPTN), 2011 – Present, Executive Committee, 2012 – Present, Chair, Operations and Funding Committee, 2012 – Present.
• Nicholas A. Peters: ACCP – Critical Care PRN Recognition Committee Chair, SCCM In-Training Section Member-at-Large.
• April Miller Quidley: North Carolina Association of Pharmacists – Acute Care Forum.
• Megan Rech: SCCM CCP Research Committee Critical Care Pharmacotherapy Literature Update (CCPLU) Charge Leader.
• Denise Rhoney: Chair, ACCP Research Institute Board of Trustees Board of Directors, Neurocritical Care Society.
• Pamela Smithburger: Vice Chair of the SCCM Quality and Safety Committee, Chair of the Critical Care PRN.
• Ann Spry: Education Committee, state organization KCHP.
• Antonia Vilella: Chair – Student, Resident, Fellow Crit Care PRN Committee.
• Johnathan Voss: Secretary/Treasurer of the GI/Liver/Nutrition PRN of ACCP.
• Craig Whitman: Treasurer, Mid-Atlantic College of Clinical Pharmacy.

 

Other

• Jonathan Bain: American College of Clinical Pharmacy Member Spotlight.
• Christine Groth: RSI abstract chosen to be presented at SCCM in February 2016 in the Research Snapshot Theatre.
• Christopher Michaud: Certificate of Achievement and Appreciation from Spectrum Health for performing 20 minutes of out-of-hospital CPR/BLS before ambulance arrival to a patient who ultimately underwent emergency catheterization and four-vessel CABG. Patient made a full cardiac and neurological recovery.

 

Awards

• Sherrill Brown: Kappa Epsilon Career Achievement Award 2015.
• Dianne May: Outstanding Committee Chair from the Georgia Society of Health-System Pharmacists.

 

Publications

• Mantovani EH, Naples JG, Rothrock-Christian T, Brown JN. Assessment of postgraduate year two pharmacy residency programs within the Veterans Affairs healthcare system. 2015 ASHP National Residency Preceptors Conference; Washington, DC.
• Naples JG, Mantovani EH, Rothrock-Christian T, Brown JN. Assessment of postgraduate year two pharmacy residency programs within the Veterans Affairs healthcare system. J Pharm Pract 2016 Jan 21. [Epub ahead of print]
• Wolff ML, Cruz JL, Vanderman AJ, Brown JN. The effect of angiotensin II receptor antagonists on hyperuricemia. Ther Adv Chronic Dis 2015;6:339-46.
• Zullig LL, Sanders LL, Thomas S, Brown JN, Danus S, McCant F, Bosworth HB. Health beliefs and desire to improve cholesterol levels among patients with hyperlipidemia. Patient Educ Couns 2015 Nov 27. [Epub ahead of print]
• Gross AE, Bryson ML. Oral ribavirin for the treatment of noninfluenza respiratory viral infections: a systematic review. Ann Pharmacother 2015;49:1125-35.
• Gosser RA, Arndt RF, Schaafsma K, Dang CH. Pharmacist impact on ischemic stroke care in the emergency department. J Emerg Med 2016.
• Hager K, Gosser RA. Retrospective analysis of billing at a standalone medication therapy management clinic. AJHP 2016.
• May DW, Bryant J. How to prepare an effective journal club. In: Gabay M, ed. The Clinical Practice of Drug Information, 1st ed, Burlington, MA: Jones & Bartlett, 2015:291-309.
• Landi M, Springer S, Estus E, Ward K. The impact of a student-run journal club on pharmacy students’ self-assessment of critical appraisal skills. Consult Pharm 2015;30:356-60.
• Ward KE, Cohen LB. Promoting safe use of medications: providing medication education to seniors receiving meals on wheels. Consult Pharm 2015;30:616-22.
• Gomes DM, Ward KE, LaPlante KL. Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus. Pharmacotherapy 2015;35:424-32.
• Phillips J, Ward KE. Descriptive statistics. In: Gabay MP, ed. The clinical practice of drug information, 1st ed. Burlington, MA: Jones & Bartlett, 2015:141-52.

 

Other Notable Achievements

• Andrew Abe: Started a new position as a Clinical Pharmacist at AlohaCare.
• Sherrill Brown: Appointed Chair of the Library and Information Sciences Section of AACP.
• Conor Hanrahan: Appointed Manager of Drug Information Services for Intermountain Healthcare.
• Dianne May: Named Fellow of the American College of Clinical Pharmacy. Also promoted to Clinical Professor for the University of Georgia College of Pharmacy.
• Ryan Rodriguez: Appointed to Residency Program Director, PGY2 Drug Information Residency, University of Illinois at Chicago/Takeda Pharmaceuticals.
• James Wall (Pharm.D. Candidate 2016): Rutgers Pharmaceutical Industry Post-Doctoral Fellow, Clinical Operations – Oncology at Genentech (San Francisco); first place at the CSHP Clinical Skills Competition (San Diego, California) in October 2015.

 

Introduction

The EDTR PRN had a successful 2015 Global Conference. Together with our program on maximizing learner assessment and developing metacognitive skills, we hosted the Student and Resident Mock Interviews during our business meeting. We also held a silent auction, which raised more than $600. The officers would like to thank all the members who participated in these events and welcome new members to the PRN. In addition, we thank the members who volunteered to be on committees for the year. The EDTR PRN would like to acknowledge and congratulate all of its members on their accomplishments during the past 6 months.

 

Awards

• Amelia Sofjan: 2016 AACP New Investigator Award.
• Mate M. Soric: ASHP Best Practices Award 2015.

 

Grants

• P. Brandon Bookstaver: Interprofessional education in HIV. Funding agency: Human Resources and Services Administration.

 

Publications

PEER REVIEWED

• Benavides S, Madzhidova S, Hernandez A, Le T, Palma SM, Stephen S. Establishment of pediatric medication therapy management: a proposed model. Pharmacy 2016;4(1). [Epub ahead of print]
• Bookstaver PB, Foster J, Lu ZK, Mann J, Ambrose C, Grant A, Burgess S. Hepatitis B virus seroconversion rates among health sciences students in the southeastern United States. J Am Coll Health 2016;64:69-73.
• Hammond D, Garner S, Linder M, Cousins W, Bookstaver PB. Assessment of mentor involvement with pharmacy students pursuing post-graduate residency training. Curr Pharm Teach Learn. January – February 2016.
• Yanicak A, Mohorn P, Monterroyo P, Furgiuele G, Waddington L, Bookstaver PB. Public perception of pharmacists: film and television portrayals from 1970 to 2013. J Am Pharm Assoc 2015;55:578-86.
• Caballero J, Ownby RL, Rey JA, Clauson KA. Cognitive and performance enhancing medication use to improve performance in poker. J Gambling Stud 2015 Oct 8. [Epub ahead of print]
• Thomas JE, Caballero J, Harrington CA. The incidence of akathisia in the treatment of schizophrenia with aripiprazole, asenapine and lurasidone: a meta-analysis. Curr Neuropharmacol 2015;13:681-91.
• Buckley LF, Carter DM, Matta L, Cheng JW, Stevens C, Belenkiy RM, Burpee LJ, Young MA, Weiffenbach CS, Smallwood JA, Stevenson LW, Desai AS. Intravenous diuretic therapy for the management of heart failure and volume overload in a multidisciplinary outpatient unit. JACC Heart Fail 2015 Dec 1. [Epub ahead of print]
• Peeters MJ. Practical significance: moving beyond statistical significance. Curr Pharm Teach Learn 2016;8:83-9.
• Peeters MJ. Measuring rater judgments within learning assessments—part 1: why the number of categories matters in a rating scale. Curr Pharm Teach Learn 2015;7:656-61.
• Peeters MJ. Measuring rater judgments within learning assessments—part 2: a mixed approach to creating rubrics. Curr Pharm Teach Learn 2013;7:662-8.
• Peeters MJ, Gundrum TE, Murphy JA. Comparing vertical and horizontal screening methods for pharmacy resident candidates before interviews. Inov Pharm 2015;6:Article 206.
• Boyle JA, Soric MM. Impact of tranexamic acid in total knee and hip replacement. J Pharm Pract 2015. [Epub ahead of print]
• Martin SL, Williams E, Huerth B, Robinson JD. A pharmacy student facilitated interprofessional diabetes clinic with the Penobscot Nation. Prev Chronic Dis 2015;12:150295.

 

NON–PEER REVIEWED

• Peeters MJ, Harpe S, Cor MK, Janke KK. Announcing a new journal section: methodology matters. Curr Pharm Teach Learn 2015;7:563-4.
• Peeters MJ, Kelly CP, Cor MK. Summative evaluations when using an objective structured teaching exercise. Am J Pharm Educ 2015;79:Article 60.
• Peeters MJ, Whitner JB, Bale AO. More evidence of professionalism and professional engagement. Inov Pharm 2015;6:Article 219.
• Hoover MJ, Peeters MJ. Does discussion of learning assessments belong in postgraduate teaching and learning curricula? Am J Health Syst Pharm 2015;72:687-8.
• Righi AM, Peeters MJ, Dotson B. Electrolyte and acid-base disturbances in patients with diabetes mellitus. N Engl J Med 2015;373:2481-2.

 

Abstracts

• Peeters MJ. Developing critical thinking: one institution’s experience. Am J Pharm Educ 2015;79:Article S4.
• Peeters MJ, Chen Y. Validation of the SPICE-R. Am J Pharm Educ 2015:79:Article S4.
• King PK, Schneiderman JF, Salama HG, Peeters MJ. Phase 2 of interprofessional high-fidelity code blue simulation: effect of repeated scenarios and modified debriefing formats. Am J Pharm Educ 2015;79:Article S4.
• Lengel AJ, Mauro LS, Schroeder MN, Peeters MJ. Facilitating personal development in PharmD students. Am J Pharm Educ 2015;79:Article S4.
• Metz A, Chen Y, Sexton M, Peeters MJ. Interprofessional education: assessment outcomes. Presented at: Collaboration Across Borders V 2015 International Conference.
• Reale M, Witt BA, Riche DM, Baker WL, Peeters MJ. Development of critical thinking among health professions students: a meta-analysis of longitudinal studies. Am J Pharm Educ 2015;79:Article S4.
• Sexton M, Ohlinger MO, Masterson M, Peeters MJ. Interprofessional education: course implementation. Presented at: Collaboration Across Borders V 2015 International Conference.
• Vaidya VA, Peeters MJ. Development of professionalism: one institution’s experience. Am J Pharm Educ 2015;79:Article S4.

 

New ACCP Fellows

• Michelle L. Hilaire

 

Other Notable Achievements

• Sandra Benavides (Guest Editor), with Richard Parrish, for special issue “Pharmacy Pediatrics” in Pharmacy (see www.mdpi.com/journal/pharmacy/special_issues/pharmacy-paediatrics).
• Thad McGiness: Resident member of the PRN received a position as Assistant Professor of Clinical Pharmacy at Philadelphia College of Pharmacy.

 

Introduction

Congratulations to members of the EMED PRN for the many achievements listed in this news brief. Recently, PRN members have been engaged in a national survey of emergency medicine pharmacy practice in the United States. The survey provides information regarding the training, activities, staffing, and hours of coverage of EM pharmacists nationally. Stay tuned for this important article and the accompanying editorial, to be published in the March issue of the American Journal of Health-System Pharmacy.

 

Promotions

• Erica Merritt: PGY2 Emergency Medicine Residency Director.
• Megan Rech: PGY2 Critical Care Residency Program Director.
• Kristan Vollman: PGY1 Pharmacy Residency Co-Coordinator for Owensboro Health (program started in 2014; awarded full 6-year ASHP accreditation in fall 2015).
• Kyle Weant: Emergency Medicine Clinical Pharmacy Specialist, Medical University of South Carolina.

 

Awards

• Megan Musselman: ACCP 2015 New Clinical Practitioner Award.
• Sid Patanwala: Drake University Alumni Achievement Award.
• Suprat Saely Wilson: ASHP New Preceptor Award.

 

Grants

• Sandy Bartlett: Husson University School of Pharmacy (HUSOP) Starter Grant: “Oritavancin Assay Development Pilot Study,” 07/01/15 – 06/30/16, direct costs $4000. (PI)

 

Publications

• Acquisto NM, Hays DP. Emergency medicine pharmacy: still a new clinical frontier. Am J Health Syst Pharm 2015;72:2092-6.
• Adams CB, Vollman KE, Leventhal EL, Acquisto NM. Emergent pediatric anticoagulation reversal using a 4-factor prothrombin complex concentrate. Am J Emerg Med 2015 Oct 26. [Epub ahead of print]
• Bartlett SC. Clinical pearl – Holy Grail of NOAC reversal agent may be in the pipeline. MSHP Bull 2015;1:3.
• Bartlett SC. A cup of cool water. Am J Health Syst Pharm 2015;72:1496-8.
• Barton CA, Johnson NB, Case J, Warden B, Hughes D, Zimmerman J, Roberti G, McMillian WD, Schreiber M. Risk of thromboembolic events after protocolized warfarin reversal with 3-factor PCC and factor VIIa. Am J Emerg Med 2015;33:1562-66.
• Barton CA, Johnson N, Mah N, Beauchamp GA, Hendrickson R. Successful treatment of a massive metoprolol overdose using intravenous lipid emulsion and hyperinsulinemia/euglycemia therapy. Pharmacotherapy 2015.
• Shenk E, Barton CA, Mah ND, Ran R, Hendickson RG, Watters J. Respiratory depression in the intoxicated trauma patient: are opioids to blame? Am J Emerg Med. In press.
• Minejima E, Bensman J, She RC, Mack WJ, Tuan Tran M, Ny P, Lou M, Yamaki J, Nieberg P, Ho J, Wong-Beringer A. A dysregulated balance of proinflammatory and anti-inflammatory host cytokine response early during therapy predicts persistence and mortality in Staphylococcus aureus bacteremia. Crit Care Med 2015 Nov 4. [Epub ahead of print]
• Moise PA, Culshaw DL, Wong-Beringer A, Bensman J, Lamp KC, Smith WJ, Bauer K, Goff DA, Adamson R, Leuthner K, Virata MD, McKinnell JA, Chaudhry SB, Eskandarian R, Lodise T, Reyes K, Zervos MJ. Comparative effectiveness of vancomycin versus daptomycin for MRSA bacteremia with vancomycin MIC >1 mg/L: a multicenter evaluation. Clin Ther 2016;38:16-30.
• Corrigan M, Wilson SS, Hampton J. Review of intranasally administered medications in the emergency department and prehospital setting. Am J Health Syst Pharm 2015;72:1544-54.
• Dellay B, Groth ME. Emergency management of malignancy-associated hypercalcemia. Adv Emerg Nurs J 2016;38:15-25.
• Redfern J, Wasilko SM, Groth ME, McMillian WD, Bartlett CS. Evaluation of infection rates among patients who received piperacillin/tazobactam versus cefazolin plus gentamicin for type III open fracture prophylaxis in a rural medical center. J Orthoped Trauma. [Published online ahead of print]
• Musselman ME. Potassium disorder. In: Canada T, Tajchman SK, Tucker A, et al., eds. ASPEN Fluids, Electrolytes, and Acid-base Disorders Handbook, 1st ed. Silver Spring, MD: American Society for Parental and Enteral Nutrition.
• Harbison AF, Polly D, Musselman ME. Safe and effective use of anti-infectives in pregnancy and lactation in the emergency department. Am J Health Syst Pharm 2015;72:189-97.
• Patanwala AE, Kurita A, Truong E. Low-dose levetiracetam for seizure prophylaxis after traumatic brain injury. Brain Inj 2015;30:1-3. [Epub ahead of print]
• Patanwala AE, Martin JR, Erstad BL. Ketamine for analgosedation in the intensive care unit: a systematic review. J Intensive Care Med 2015 Dec 8. [Epub ahead of print]
• Aljuhani O, Kopp BJ, Patanwala AE. Effect of methocarbamol on acute pain after traumatic injury. Am J Ther 2015 Oct 8. [Epub ahead of print]
• Altyar A, Bakhsh HT, Mohammed A, Skrepnek G, Patanwala AE. Administration of first dose antibiotic in the ED in patients with minor skin and soft tissue infections. Am J Emerg Med 2015;33:1225-8.
• Amini R, Stolz LA, Patanwala AE, Adhikari S. Coronal axis measurement of the optic nerve sheath diameter using a linear transducer. J Ultrasound Med 2015;34:1607-12.
• Rhodes SM, Patanwala AE, Cremer JK, Marshburn ES, Herman M, Shirazi FM, Harrison-Monroe P, Wendel C, Fain M, Mohler J, Sanders AB. Predictors of prolonged length of stay and adverse events among older adults with behavioral health-related emergency department visits: a systematic medical record review. J Emerg Med 2016;50:143-52.
• Sakles JC, Mosier JM, Patanwala AE, Dicken JM, Kalin L, Javedani PP. The C-MAC® video laryngoscope is superior to the direct laryngoscope for the rescue of failed first-attempt intubations in the emergency department. J Emerg Med 2015;48:280-6.
• Radosevich JJ, Patanwala AE, Erstad BL. Norepinephrine dosing in obese and nonobese patients with septic shock. Am J Crit Care 2016;25:27-32.
• Radosevich JJ, Patanwala AE, Frey PD, Lee YG, Paddock H, Erstad BL. Higher insulin infusion rate but not 24-h insulin consumption is associated with hypoglycemia in critically ill patients. Diabetes Res Clin Pract 2015;110:322-7.
• Rech MA, Bennett S, Chaney W, Sterk E. Risk factors for mortality in septic patients who received etomidate. Am J Emerg Med 2015;33:1340-3.
• Rech MA, Day SA, Kast, JA, et al. Major publications in the critical care pharmacotherapy literature: January 2013 through December 2013. Am J Health Syst Pharm 2015;72:224-36.
• Rech MA, Wittekindt L, Friedman SD, Kling K, Ubogy D. Prothrombin complex concentrate for intracerebral hemorrhage secondary to vitamin K deficiency bleeding in a 6-week-old child. J Pediatr 2015;167:1443-4.
• Czeck EE, Quinn AL, Rech MA. Opioid and common co-ingestant antidotes, drug overdoses and alcohol withdrawal: prevalence, trends and prevention. In: Morales DP, ed. ISBN: 978-1-63483-873-3. https://www.novapublishers.com/catalog/product_info.php?products_id=56133.
• Day S, Cucci M, Droege M, Erdman M, Holzhausen J, Kram B, Kram S, Pajoumand M, Parker C, Patel M, Peitz G, Poore A, Turck C, Van Berkel M, Wong A, Zomp A, Rech MA. Major publications in the critical care pharmacotherapy literature: January 2014 through December 2014. Am J Health Syst Pharm 2015;72:1974-85.
• Robey-Gavin E, Abuakar L. Impact of clinical pharmacists on initiation of postintubation analgesia in the emergency department. J Emerg Med 2016;50:308-14.
• Thomas MC. Health maintenance/public health I. In: Bainbridge JL, Branham A, Coyle EA, et al. Updates in Therapeutics^®: The Ambulatory Care Pharmacy Preparatory Review and Recertification Course, 2015 ed. Lenexa, KS: American College of Clinical Pharmacy, 2015:2-673-2-705.
• Thomas MC, Acquisto NM, Shirk MB, Patanwala AE. A national survey of pharmacy practice in the United States. Am J Health Syst Pharm 2016. In press.
• Thomas MC, Shewmaker J, Musselman M. Droperidol for the treatment of acute migraine headaches. Ann Pharmacother 2015;49:223-40.
• Thomas MC, Sun S. Advanced pharmacy practice experiences for pharmacy students in emergency department settings. Curr Phar Teach Learn 2015;7:378-81.
• Macias-Moriarity LZ, Fetterman JW, Thomas MC, Stajich GV. Residency program director’s perception of PGY-1 applicants: results of the national 35½ second survey. Curr Phar Teach Learn 2015;7:465-9.
• Mo Y, Thomas MC, Karras GE. Barbiturates for the treatment of alcohol withdrawal syndrome: a systematic review of clinical trials. J Crit Care 2016.
• Mo Y, Zimmermann AE, Thomas MC. Practice patterns and opinions on current clinical practice guidelines regarding the management of delirium in the intensive care unit. J Pharm Pract 2016.
• Ware KB, Thomas MC, Stajich Macias-Moriarity LZ. Learning new tricks: an assessment of novel versus traditional patient counseling strategies. Curr Phar Teach Learn 2015;7:584-9.
• Johnson EG, Meier A, Shirakbari A, Weant K, Baker Justice S. Impact of rocuronium and succinylcholine on sedation initiation after rapid sequence intubation. J Emerg Med 2015;49:43-9.
• Bailey AM, Stephan M, Weant KA, Baker Justice S. Dosing of appropriate antibiotics and time to administration of first doses in the pediatric emergency department. J Pediatr Pharmacol Ther 2015;20:309-15.
• Schultz AE, Lewis T, Reed BS, Weant KA, Baker Justice S. That’s a phat antidote: intravenous fat emulsions and toxicological emergencies. Adv Emerg Nurs J 2015;37:162-75.
• Wilson SS, Ayaz SI, Levy PD. Relaxin: a novel agent for the treatment of acute heart failure. Pharmacotherapy 2015;35:315-27.
• Kumar VA, Wilson SS, Ayaz SI, Levy PD. Targeted biological therapies reach the heart: the case of serelaxin for heart failure. Drugs Today 2015;51:591-7.
• O’Connor JM, Nefcy A, Wilson SS. Severe mucositis after acute substance ingestion. Clin Toxicol 2015;53:578-9.
• Raub JN, Thurston TM, Fiorvento AD, Mynatt RP, Wilson SS. Implementation and outcomes of a pharmacy residency mentorship program. Am J Health Syst Pharm 2015;72:S1-S5.
• Zimmerman DE. Anti-epileptics. In: Shank BR, Zimmerman DE, eds. Demystifying Drug Dosing in Obese Patients. Bethesda, MD: American Society of Health-System Pharmacists, 2016:97-107.
• Shank BR, Zimmerman DE, eds. Demystifying Drug Dosing in Obese Patients. Bethesda, MD: American Society of Health-System Pharmacists, 2016.

 

New ACCP Fellows

• Sid Patanwala
• Michael C. Thomas

 

Other Notable Achievements

• Sarah Barlow: Board Certified Critical Care Pharmacist (BCCCP).
• Sandy Bartlett: Board Certified Critical Care Pharmacist (BCCCP).
• Cassie A. Barton: Board Certified Critical Care Pharmacist (BCCCP).
• Molly Mason: Board Certified Critical Care Pharmacist (BCCCP).
• Megan Musselman: Board Certified Critical Care Pharmacist (BCCCP).
• Kristan Vollman: Board Certified Pharmacotherapy Specialist (BCPS)

 

Promotions

• Molly Minze: Associate Professor at Texas Tech University Health Sciences Center School of Pharmacy, effective September 2015.
• Heather Whitley: Co-Director of Research at Montgomery Family Medicine Residency Program at Baptist Health in Montgomery, Alabama. Also fully employed by Auburn University.

 

Awards

• Amy C. Donihi: Selected as a 2015 recipient of the Richard L. Simmons Speak Up for Patient Safety Award at the University of Pittsburgh Medical Center. Donihi received this award in recognition of the work she has done during the past 15 years as a member of the Diabetes Patient Safety Committee to improve the glycemic management and safety of people with diabetes or newly recognized hyperglycemia in the hospital setting.

 

Grants

• Whitley HP, Green P. “Multidisciplinary and Diabetes Classes Program in an Outpatient Family Medicine Clinic.” 2015–2016. Baptist Health Care Foundation. $12,868.50 on November 10, 2015. Status: Funded. (Co-PI)
• Whitley HP, Green P. Baptist Health DSME Program. 2015–2016: Alabama Department of Public Health. $10,000 on September 2015. Status: Funded. (Co-PI)

 

Publications

• Clements J, Whitley HP, D’Souza JJ, Gross B, Hess R, Reece S, Gentry C, Shealy K. Sodium glucose co-transporter inhibitors for the management of diabetes mellitus: An opinion paper from the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy. Curr Med Res Opin 2015;31:1733-41.
• Sobel SI, Augustine M, Donihi AC, Reider J, Forte P, Korytkowski M. Safety and efficacy of a peri-operative protocol for patients with diabetes treated with continuous subcutaneous insulin infusion who are admitted for same-day surgery. Endocr Pract 2015;21:1269-76.
• Goldman JD, White JR. New insulin glargine 300 U/ml for the treatment of type 1 and type 2 diabetes mellitus. Ann Pharmacother 2015;49:1153-61.
• Patel D, Charkoudian M, Goldman JD, Couris R. Focus on hypoglycemia: patient education, disease management and prevention. Nutr Today 2015;50:277-81.
• Minze MG, Koffarnus RL, Bailey TA, Diec S, Edwards KL. Sodium-glucose co-transporter 2 inhibitors: evidence and place in therapy. Expert Rev Endocrinol Metabol 2015;10:645-61.
• Minze MG, Kwee Y, Hall RG III. Low-molecular-weight heparin prophylaxis dosing: is weight an issue? J Pharm Technol. [Published online November 18, 2015]
• Elliott JE, Reece SW. Insulin therapy: new options. Pract Diabetol 2015;34:15-7.
• Whitley HP, Hanson C, Parton JM. Improving the undiagnosed rate of diabetes mellitus using a point-of-care A1C device. J Diabetes Metab Disord Control 2015;2:00025.
• Whitley HP, Yong EV, Rasinen C. Selecting an A1C point-of-care instrument. Diabetes Spectr 2015;28:201-8.

 

Presentations

• Stamm PL, Andrus MR. Has the smoked cleared? Debating eCigarettes. Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; December 2015; New Orleans, LA.

 

New ACCP Fellows

• Michelle L. Hilaire

• Daniel Riche

 

Other Notable Achievements

• Kayley Will: Board Certification in Advanced Diabetes Management, December 5, 2015.

 

Introduction

The Geriatrics PRN reports a successful 2015 Global Conference. Forty-two posters were presented by PRN members; the PRN gave three student awards and one resident travel award; and new officers for 2015–2016 were introduced. The PRN is proud of the recent accomplishments of its members, including the following.

 

Promotions

• Gregory Hughes: Associate Clinical Professor, Clinical Health Professions, St. John’s University College of Pharmacy and Health Sciences.
• Jeannie Lee: Assistant Head, Pharmacy Practice and Science, University of Arizona College of Pharmacy.

 

Awards

• Rejena Azad: 2015 Texas Society of Health-System Pharmacists Innovative Collaborative Practice Award: Houston Methodist Hospital System’s “Implementing Systematic Pharmacy Initiatives for Delirium Mitigation by Reducing High-risk Medication Use.”
• Rejena Azad: 2015 American Society of Health-System Pharmacists Award for Excellence in Medication-Use Safety: Houston Methodist Hospital System’s “Clinical Management of High-Risk Medication Use to Mitigate the Incidence of Hospital-Acquired Delirium in the Geriatric Population.”
• Ashley Campbell, Jason Corbo, Heather Sakely: First-place awardee for Resident and Fellow Abstract, Models of Care Category, AGS 2015: Campbell A, Coley K, Thorpe C, Corbo J, McGivney M, Klatt P, Zaharoff J, Cox-Vance L, Sakely H. The impact of pharmacists caring for geriatric patients across the healthcare continuum on the identification, resolution, and prevention of drug therapy problems: a subset of the PIVOTS (Pharmacist-led Interventions on the Transitions of Seniors) group. J Am Geriatr Soc 2015;63(suppl 1):S265.
• Kalin Clifford: 2014–2015 Dallas Faculty Preceptor of the Year.
• Jason Corbo and Heather Sakely: Second-place awardee for Resident and Fellow Abstract, Models of Care Category, AGS 2015: Breslin T, Durigan R, Payette N, Bacci J, Klatt P, McGivney M, Corbo J, Coley K, Thorpe C, Cox-Vance L, Zaharoff J, Sakely H. Physician perceptions of pharmacists integrated within their practice: a mixed methods analysis of effects on patient care and non-patient care activities. J Am Geriatr Soc 2015;63(suppl 1):S270.
• Jason Corbo and Heather Sakely: Third-place awardee for Resident and Fellow Abstract, Models of Care Category, AGS 2015: Higbea AM, Thorpe C, Cox-Vance L, McGivney M, Coley K, Schleiden L, Zaharoff J, Corbo J, Klatt P, Sakely H. Improving care of older adults within a novel practice: patient perceptions and self-efficacy analysis of Pharmacist-led InterVentions On Transitions of Seniors (PIVOTS) by patient surveys. J Am Geriatr Soc 2015;63(suppl 1):S265.
• Jeannie Lee: Arizona Geriatrics Society 2015 Geriatrician of the Year.
• Patricia Slattum: American Society of Consultant Pharmacists 2015 Armon Neel Senior Care Pharmacist Award.
• Barbara Zarowitz: American Society of Consultant Pharmacists 2015 George F. Archambault Award.

 

Grants

• Gregory Hughes: St. John’s University SBIRT-Student Training, around $900,000 over 3 years, a Substance Abuse and Mental Health Services Administration Grant-Funded Program.
• Jeannie Lee: Health Resources and Services Administration UIQHP28721 for “Arizona Geriatric Workforce Enhancement Program” to develop a capable, diverse, and culturally competent Arizona health professions workforce focused on ensuring the improvedhealth outcomes ofArizona’s older adult population including function and quality of life; 09/01/15 – 08/31/18. (Co-I)
• Jeannie Lee: Banner Health Innovations Grant for “Supporting Function in At-Risk Elders: Early Identification of Frailty in an Ambulatory Setting” to confirm a sensitive low-cost intervention to accurately identify clinical and physical characteristics predictive of the risk of frailty and identify a clinical intervention (e.g., systematic medication reduction) to prevent or reduce frailty; 01/16 – 05/16. (Co-I)
• Emily Peron: White J, Richards M, Peron EP, Finucane S, Williams T, Rubin S. PALETTE in Motion; 07/01/2015 – 06/30/2016. Virginia Commonwealth University Council for Community Engagement: $19,070.
• Katie L. Traylor: American Society of Health-System Pharmacists Research and Education Foundation Pharmacy Resident Practice-Based Research Grant for “Aspirin Prescribing Practices for Primary Stroke Prevention in Elderly Women Following Monthly Population-Based Clinical Pharmacist Evaluation.”

 

Publications

• Richards R, Azad R, Adeola M, Clark B. Delirium: the 21st century health care challenge for bedside clinicians. J Nurs Educ Pract 2016;6:8-16.
• Caballero J, Ownby RL, Rey JA, Clauson KA. Cognitive and performance enhancing medication use to improve performance in poker. J Gambl Stud 2015. [Epub ahead of print]
• Thomas JE, Caballero J, Harrington CA. The incidence of akathisia in the treatment of schizophrenia with aripiprazole, asenapine and lurasidone: a meta-analysis. Curr Neuropharmacol 2015;13:681-91.
• Clifford KM, Dy-Boarman EA, Haase KK, Maxvill K, Pass SE, Alvarez CA. Challenges with diagnosis and managing sepsis in older adults. Expert Rev Anti Infect Ther 2016;14:231-41.
• Bradley-Baker LR, Taylor CT, Adams AJ, Albert EL, Cardello EA, Clifford KM, Currie JD, Gonyeau M, Nelson SP. Report of the 2014–2015 Professional Affairs Standing Committee: producing practice-ready pharmacy graduates in an era of value-based health care. Am J Pharm Educ 2015;79:S12.
• Duncan NA, Clifford KM, Shvarts OM. Mirtazapine-associated hypertriglyceridemia and hyperglycemia. Consult Pharm 2015;30:657-63.
• Eisenhower C, Koronkowski M, Marcum Z. Implications of recent drug approvals for older adults. Ann Longterm Care 2016;24:25-30.
• Pauff BR, Jiroutek MR, Holland MA, Sutton BS. Statin prescribing patterns: an analysis of data from patients with diabetes in the national hospital ambulatory medical care survey outpatient department and national ambulatory medical care survey databases, 2005-2010. Clin Ther 2015;37:1329-39.
• Payk SL, Drew RH, Smith JD, Jiroutek MR, Holland MA. Sulfonylurea prescribing patterns after the introduction of DPP-4 inhibitors and GLP-1 receptor agonists. Clin Ther 2015;37:1477-82.
• Hutchison L: The American Geriatrics Society Expert Panel on Post-operative Delirium in Older Adults. American Geriatrics Society abstracted clinical practice guideline for postoperative delirium in older adults. J Am Geriatr Soc 2015;63:142-50.
• Hutchison LC, Sleeper-Irons RB, eds. Fundamentals of Geriatric Pharmacotherapy: An Evidence-Based Approach, 2nd ed. Bethesda, MD: American Society of Health-System Pharmacists, 2015.
• Berryman SN, Huff DC, Hutchison LC, Bilbruck TJ, Ragsdale PS, Jennings JE, Greenfield TM. Integrating collaborative interprofessional simulation into pre-licensure healthcare programs. Nurs Educ Perspect 2015;36:396-7.
• Brown J, Hutchison LC, Li CH, Painter JT, Martin BC. Predictive validity of the Beers and STOPP criteria to detect adverse drug events, hospitalizations, and emergency department visits in the United States. J Am Geriatr Soc. In press.
• King A, Erickson S, Payakachat N, Hutchison LC, Said Q. Self-reported plan switching in Medicare Part D: 2006-2010. Am J Pharm Benefits 2015;6:e157-68.
• Richards KC, Bost JE, Rogers VE, Hutchison LC, Beck CK, Bliwise D, Kovach CR, Cuellar N, Allen RP. Diagnostic accuracy of behavioral, activity, ferritin, and clinical indicators of restless legs syndrome. Sleep 2015;38:371-80.
• Lee JK, Alshehri S, Kutbi H, Martin J. Optimising pharmacotherapy in elderly patients: the role of pharmacists. Integrat Pharm Res Pract 2015;4:101-11.
• Karmegam S, Lee JK. Management of persistent pain in older adults. Ariz Geriatr Soc J 2015;20:29-30.
• Kligler B, Brooks AJ, Maizes V, Goldblatt E, Klatt M, Koithan MS, Kreitzer MJ, Lee JK, Lopez AM, McClafferty H, Rhode R, Sandvold I, Saper R, Taren D, Wells E, Lebensohn P. Interprofessional competencies in integrative primary healthcare. Glob Adv Health Med 2015;4:33-9.
• Mohler J, Fain M, Chen Z, Lee JK, Thienhaus OJ. Letter to the editor: comment/responses depression, antidepressants, and bone health in older adults: a systematic review. J Am Geriatr Soc 2015;63:623-4.
• Lam S, Mondiello T. Discontinuation of memantine standard release and its impact on patient therapy. Consult Pharm 2015;30:283-6.
• Rubin SE, Gendron TL, Wren CA, Ogbonna KC, Gonzales EG, Peron EP. Challenging gerontophobia and ageism through a collaborative intergenerational art program. J Intergen Rel 2015;13:241-54.
• Ahmed-Sarwar N, Pierce DP, Holub DC. COPD: optimizing treatment. J Fam Pract 2015;64:610-23.
• Reidt S, Sibicky S, Yarabinec A. Transitional care units: expanding the role of pharmacists providing patient care. Consult Pharm 2016;31:44-8.
• Schafer KM, Reidt S. Herpes zoster vaccine in the long-term care setting: a clinical and logistical conundrum. Consult Pharm 2016;31:33-7.
• Harris IM, Reidt SL, Lounsbery JL, et al. Assessment of core knowledge during ambulatory care advanced pharmacy practice experiences using online modules and pre- and post-testing. Curr Pharm Teach Learn 2016;8:213-9.
• Sakely H, Corbo J, Coley M, Thorpe C, Klatt P, Schleiden L, Zaharoff J, Cox-Vance L, Balestrino V, McGivney MS. Pharmacist-led collaborative practice for older adults. Am J Health Syst Pharm 2015;72:606-9.
• Semla T, Beizer J, Linnebur S. The American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2015;63:2227-46.
• Min Y, Kirkwood CK, Mays DP, Slattum PW. The effect of sleep medication use and poor sleep quality on risk of falls in community-dwelling older adults in the US: a prospective cohort study. Drugs Aging 2016;33:151-8.
• Blaszczyk AT, Sleeper-Irons RB, Bailey TA, Duncan NA, McCarrell JL, Clifford KM. Workarounds during the transcription of medication orders in the long-term care setting. Ann Longterm Care 2015;23:33-7.
• Traylor KL, Babin J, Witt D. Laboratory monitoring of low-molecular-weight heparin and fondaparinux. Semin Thromb Hemost. In press.
• Traylor KL, Gunning K, Pippitt K. Team-based care: relationships, not algorithms. J Am Board Fam Med. In press.
• Vouri SM, Stranges PM, Burke JM, Micek S, Pitlick MK, Wenger P. The importance of research during pharmacy residency training. Curr Pharm Teach Learn 2015;7:892-8.
• Vouri SM, Stranges PM, Nissen J. Comment on: validity and reliability of a systematic database search strategy to identify publications resulting from pharmacy residency research projects. J Pharm Pract 2015;28:497-8.
• Stranges PM, Vouri SM, Bergfeld F, Crain M, Jindal N, Landrum M, Lindauer S, Mueller Z, Reich A. Pharmacy resident publication success: factors of success based on abstracts from a regional meeting. Curr Pharm Teach Learn 2015;7:780-6.

 

New ACCP Fellows

• Dianne W. May
• Joseph P. Vande Griend

 

Other Notable Achievements

• Nicolette Centanni: Certified Geriatric Pharmacist.
• Stephanie (Seaton) Crist: President-Elect, Missouri Chapter of American Society of Consultant Pharmacists.
• Jeannie Lee: National Leadership Development Program in Aging – Tideswell at University of California San Francisco, American Geriatrics Society, and Association of Directors of Geriatrics Academic Programs: www.tideswellucsf.org/tideswell-ags-adgap-national-leadership-development-program/.
• Emily Peron: Member, Phi Kappa Phi Honor Society.
• Scott Vouri: Fellow, American Society of Consultant Pharmacists.

 

Introduction

The GILN PRN would like to congratulate members on the following accomplishments from September 2015 to February 2016. We hope to see you at the spring ACCP meeting if you are planning to attend!

 

Publications

• Dickerson RN, Voss JR, Schroeppel TJ, et al. Feasibility of jejunal enteral nutrition for patients with severe duodenal injuries. Nutrition 2016;32:309-14.
• Deming P, Martin M, Chan J, et al. Therapeutic advances in HCV genotype 1 infection. SIDP Newsletter 2015;Fall:17-34.
• Smith MA, Regal RE, Mohammad RA. Daclatasvir: a NS5A replication complex inhibitor for hepatitis C infection. Ann Pharmacother 2016;50:39-46.
• Smith MA, Love BL, Mohammad RA. The changing landscape of adverse drug events associated with chronic hepatitis C virus therapy. Expert Opin Drug Saf 2015;14:1649-52.

 

Presentations

• Martin MT. Advances in hepatitis C virus treatment. Developed and presented a 1-hour CE program for pharmacists, physicians, and nurses for: 2016 Winter Milwaukee Conference: Updates in Specialty Pharmacy: Managing Chronic Diseases with Complex Pharmaceuticals. University of Wisconsin Division of Pharmacy Professional Development; January 31, 2016; Brookfield, WI.
• Martin MT. The role of a pharmacist in liver clinic, hepatitis C virus, hepatitis B virus, and the management of advanced liver disease. Developed and presented a 6.5-hour CE program for pharmacists at: Singapore General Hospital; November 15, 2015; Singapore.
• Martin MT. Advances in hepatitis C virus treatment. Developed and presented a 1-hour CE program for pharmacists and nurses at: Singapore General Hospital; November 13, 2015; Singapore.
• Martin MT. Advances in hepatitis C virus. 2015 Carle Foundation Day. Developed and presented a 45-minute CE presentation and developed and led a 75-minute case presentation and interdisciplinary panel discussion program; November 5, 2015; Champaign, IL.
• Smith AN. Understanding the use of obesity medications: when, why and how. Invited faculty. Obesity Week (combined annual meeting of the Obesity Society and the American Society for Metabolic & Bariatric Surgery); November 3, 2015; Los Angeles, CA.
• Smith AN. VTE prophylaxis strategies. Invited faculty. Obesity Week (combined annual meeting of the Obesity Society and the American Society for Metabolic & Bariatric Surgery); November 3, 2015; Los Angeles, CA.
• Smith AN. Weight loss medications in a post-op bariatric surgery patient. Invited faculty. Obesity Week (combined annual meeting of the Obesity Society and the American Society for Metabolic & Bariatric Surgery); November 2, 2015; Los Angeles, CA.
• Smith AN. Integrated health pharmacology course. Moderator and course developer. Invited faculty. Obesity Week (combined annual meeting of the Obesity Society and the American Society for Metabolic & Bariatric Surgery); November 3, 2015; Los Angeles, CA.

 

Awards

• Katherine Chessman: PLS Alumni Award from the MUSC chapter of SCCP.

 

Other Notable Achievements

• Katherine Chessman: Chair of the first Pediatric Specialty Council, which administered the first pediatric board certification examination in October 2015.
• Johnathan Voss: Became a Board Certified Critical Care Pharmacist (BCCCP) during the first testing period for this certification.

 

Introduction

The Global Health PRN has been organizing its 2016 committees. In its second year, the PRN is focused on defining global health pharmacy for the health care community, engaging its members in global health activities through networking and research, and initiating interagency relations to keep members informed about global health opportunities.

 

Awards

• Michelle Holm: 2016 Consortium of Universities for Global Health (CUGH) Velji Emerging Leader in Global Health Award.

 

Grants

• Kim Scarsi (PI) and Kristin Darin (Co-I). Pharmacological strategies to use the levonorgestrel implant in HIV-infected women. NIH/NICHD. 12/1/15 – 11/30/20.

 

Publications

• Gilbert EM, Darin KM, Scarsi KK, McLaughlin M. A review of antiretroviral pharmacokinetics during pregnancy. Pharmacotherapy 2015;35:838-55.
• Parikh S, Fehintola F, Huang L, Olson A, Adedeji WA, Darin KM, Morse GD, Murphy RL, Taiwo BO, Akinyinka OO, Adewole IF, Aweeka FT, Scarsi KK. Artemether-lumefantrine exposure in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy. Antimicrob Agents Chemother 2015;59:7852-6.
• Holm MR, Burkhartzmeyer HL. Implementation of a phased educational approach in a developing country. Glob Health Action 2015;11:29882.
• Deming P, Martin M, Chan J, et al. Therapeutic advances in HCV genotype 1 infection. SIDP Newsletter 2015;Fall:17-34.
• Gleason SE, Covvey JR, Abrons JP, Dang Y, Seo SW, Tofade T, Prescott GM, Peron EP, Masilamani S, Alsharif NZ. Connecting global/international pharmacy education to the CAPE 2013 outcomes: a report from the global pharmacy education special interest group. 56 p. Located at: AACP Center for the Advancement of Pharmacy Education, Alexandria, VA. www.aacp.org/RESOURCES/EDUCATION/CAPE/Pages/default.aspx.
• Scarsi KK, Darin KM, Nakalema S, Back DJ, Byakika-Kibwika P, Else LJ, Dilly-Penchala S, Buzibye A, Cohn SE, Merry C, Lamorde M. Unintended pregnancies observed with combined use of the levonorgestrel contraceptive implant and efavirenz-based antiretroviral therapy: a three-arm pharmacokinetic evaluation over 48 weeks. Clin Infect Dis 2015 Dec 8. [Epub ahead of print]
• Scarsi KK, Eisen G, Darin KM, Meloni ST, Rawizza HE, Tchetgen Tchetgen EJ, Agbaji OO, Onwujekwe DI, Gashau W, Nkado R, Okonkwo P, Murphy RL, Kanki PJ; Harvard/APIN PEPFAR team. Superior effectiveness of zidovudine compared with tenofovir when combined with nevirapine-based antiretroviral therapy in a large Nigerian cohort. Clin Infect Dis 2015 Nov 10. [Epub ahead of print]

 

Other Notable Achievements

• Martin MT. Advances in hepatitis C virus treatment. Developed and presented a 1-hour CE program for pharmacists, physicians, and nurses for: 2016 Winter Milwaukee Conference: Updates in Specialty Pharmacy: Managing Chronic Diseases with Complex Pharmaceuticals. University of Wisconsin Division of Pharmacy Professional Development; January 31, 2016; Brookfield, WI.
• Martin MT. The role of a pharmacist in liver clinic, hepatitis C virus, hepatitis B virus, and the management of advanced liver disease. Developed and presented a 6.5-hour CE program for pharmacists at Singapore General Hospital in Singapore; November 15, 2015.
• Martin MT. Advances in hepatitis C virus treatment. Developed and presented a 1-hour CE program for pharmacists and nurses at Singapore General Hospital in Singapore; November 13, 2015.
• Martin MT. Advances in hepatitis C virus. 2015 Carle Foundation Day. Developed and presented a 45-minute CE presentation and developed and led a 75-minute case presentation and interdisciplinary panel discussion program; November 5, 2015; Champaign, IL.

 

Other

• Renee Holder: Appointed to ACCP Organizational Affairs Committee.

 

Introduction

The Hematology/Oncology PRN continues to provide a forum for hematology/oncology pharmacists to network and collaborate on scientific, educational, and political issues affecting clinical practice, teaching, and research. We have grown to 1048 members, with trainees (students and residents) making up more than 50% of the PRN membership. The largest increase in overall members was among students with an 82% increase.

At the 2015 ACCP Annual Meeting, the PRN hosted resident and student travel awardees. Because of the increase in student membership and desire for more opportunities to connect, the second half of the PRN meeting served as a networking session focused on clinical and research activities of the membership. One committee of the PRN is dedicated to developing student/resident trainees.

The PRN has made plans to donate to the Frontiers Fund, and nominations for 2016 awards have been submitted. Plans for PRN collaboration are under way for the 2016 PRN focus session.

 

Grants

• Ninh (Irene) La-Beck: NIH/NCI R15CA192097-01A1 ($453,173) awarded 8/6/2015 for grant titled “Abrogating Nanoparticle-Induced Immunosuppression in Tumor Microenvironment.” (PI)

 

Awards

• The following individuals were selected as Fellows of the Hematology/Oncology Pharmacy Association 2016 (FHOPA):
• Barry Goldspiel
• Donald Harvey
• Lisa Holle
• Kelly Weddle
• Casey Williams

 

Publications

• Afifi S, Adel NG, Devlin S, Duck E, Vanak J, Landau H, Chung DJ, Lendvai N, Lesokhin A, Korde N, Reich L, Landgren O, Giralt S, Hassoun H. Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis study. Bone Marrow Transplant 2016 Jan 4. [Epub ahead of print]
• Afifi S, Michael A, Azimi M, Rodriguez M, Lendvai N, Landgren O. Role of histone deacetylase inhibitors in relapsed refractory multiple myeloma: a focus on vorinostat and panobinostat. Pharmacotherapy 2015;35:1173-88.
• Buie LW, Pecoraro JJ, Horvat TZ, Daley RJ. Blinatumomab: a first-in-class bispecific T-cell engager for precursor B-cell acute lymphoblastic leukemia Ann Pharmacother 2015;49:1057-67.
• Corkins MR. Oncology, hematopoietic transplant, gastrointestinal supportive care medications, and survivorship. The ASPEN Pediatric Nutrition Supportive Care Core Curriculum, 2nd ed. Silver Spring, MD: American Society for Parenteral and Enteral Nutrition, 2015:459-64.
• Clark SM, Clemmons AB, Schaack L, Garren J, DeRemer DL, Kota VK. Fosaprepitant for the prevention of nausea and vomiting in patients receiving BEAM or high-dose melphalan before autologous hematopoietic stem cell transplant. J Oncol Pharm Pract 2015 May 7. [Epub ahead of print]
• Hartranft ME, Clemmons AB, DeRemer DL, Kota V. Evaluation of romiplostim for the treatment of secondary failure of platelet recovery among allogeneic hematopoietic stem cell transplant patients. J Oncol Pharm Pract 2015 Oct 14. [Epub ahead of print]
• Eiland LS, Todd TJ. Chemotherapy dosing controversies. In: Advanced Pediatric Therapeutics, 1st ed. Memphis: Pediatric Pharmacy Advocacy Group, 2015:882-900.
• Baz R, Lin HM, Hui AM, Harvey RD, Colson K, Gallop K, Swinburn P, Laubach J, Berg D, Richardson P. Development of a conceptual model to illustrate the impact of multiple myeloma and its treatment on health-related quality of life. Support Care Cancer 2015 Feb 24. [Epub ahead of print]
• Jagirdar N, Harvey RD, Nooka A, Flowers C, Kaufman J, Lonial S, Lechowicz MJ, Langston A, Lipscomb C, Gaylor C, Waller EK. Plerixafor in combination with granulocyte-colony-stimulating factor after chemotherapy increases mobilization efficiency in patients with lymphoma or myeloma: results of a phase II clinical trial. Transfusion 2015 Sep 2. [Epub ahead of print]
• Owonikoko TK, Ramalingam SS, Miller DL, Force SD, Sica GL, Mendel J, Chen Z, Rogatko A, Harvey RD. Adverse event recognition and management in practice and on clinical trials: translating the Common Terminology Criteria for Adverse Events (CTCAE) [editorial]. J Hematol Oncol Pharm 2015;5:6-7.
• Sarantopoulos J, Shapiro GI, Cohen RB, Clark JW, Kauh JS, Weiss GJ, Cleary JM, Mahalingam D, Pickard MD, Faessel H, Berger AJ, Burke K, Mulligan G, Dezube BJ, Harvey RD. Phase I study of the investigational NEDD8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924) in patients with advanced solid tumors. Clin Cancer Res 2015 Sep 30. [Epub ahead of print]
• Tighiouart M, Harvey RD, Kim S, Saba NF, Pickens A, Behera M, Fu R, Rossi M, Auffermann WF, Torres WE, Bechara R, Deng X, Sun SY, Fu H, Gal AA, Khuri FR. A translational, pharmacokinetic and pharmacodynamic phase IB clinical study of everolimus in resectable non-small cell lung cancer. Clin Cancer Res 2015 Feb 11. [Epub ahead of print]
• Bray WM, Bivona C, Rockey M, Henry D, Grauer D, Abhyankar S, Aljitawi O, Ganguly S, McGuirk J, Singh A, Lin TL. Outcomes for newly diagnosed patients with acute myeloid leukemia dosed on actual or adjusted body weight. Cancer Chemother Pharmacol 2015;76:691-7.
• Holle LM, Harris CS, Chan A, Fahrenbruch RJ, Labdi BA, Mohs JE, Norris LB, Perkins J, Vela CM. Pharmacists’ roles in oncology pharmacy services: results of a global survey. J Oncol Pharm Pract 2016 Feb 6. [Epub ahead of print]
• Holle LM, Puri S, Clement JM. Physician-pharmacist collaboration for oral chemotherapy monitoring: insights from an academic genitourinary oncology practice. J Oncol Pharm Pract 2015 Apr 21. [Epub ahead of print]
• Patel JM, Holle LM, Clement JM, Bunz T, Niemann C, Chamberlin KW. Impact of a pharmacist-led oral chemotherapy-monitoring program in patients with metastatic castrate-resistant prostate cancer. J Oncol Pharm Pract 2015 Oct 22.
• Pherwani N, Ghayad JM, Holle LM, Karpiuk EL. Outpatient management of febrile neutropenia associated with cancer chemotherapy: risk stratification and treatment review. Am J Health Syst Pharm 2015;72:619-31.
• Gee JR, Saltzstein DR, Messing E, Kim K, Kolesar J, Huang W, Havighurst TC, Harris L, Wollmer BW, Jarrard D, House M, Parnes H, Bailey HH. Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy. Eur J Cancer Prev 2015 Aug 26.
• Bruce JY, Scully PC, Carmichael LL, Eickhoff JC, Perlman SB, Kolesar JM, Heideman JL, Jeraj R, Liu G. Pharmacodynamic study of axitinib in patients with advanced malignancies assessed with (18)F-3'deoxy-3'fluoro-L-thymidine positron emission tomography/computed tomography. Cancer Chemother Pharmacol 2015;76:187-95.
• Hanna NH, Dahlberg SE, Kolesar JM, Aggarwal C, Hirsch FR, Ramalingam SS, Schiller JH. Three-arm, randomized, phase 2 study of carboplatin and paclitaxel in combination with cetuximab, cixutumumab, or both for advanced nonsmall cell lung cancer (NSCLC) patients who will not receive bevacizumab-based therapy: an Eastern Cooperative Oncology Group (ECOG) study (E4508). Cancer 2015 Mar 4.
• Wisinski KB, Cantu CA, Eickhoff J, Osterby K, Tevaarwerk AJ, Heideman J, Liu G, Wilding G, Johnston S, Kolesar JM. Potential cytochrome P-450 drug-drug interactions in adults with metastatic solid tumors and effect on eligibility for phase I clinical trials. Am J Health Syst Pharm 2015;72:958-65.
• La-Beck NM, Jean GW, Huynh C, Alzghari SK, Lowe DB. Immune checkpoint inhibitors: new insights and current place in therapy. Pharmacotherapy 2015;35:963-76.
• Gabizon A, La-Beck NM. Optimizing nanoparticle delivery of chemotherapeutics. In: Cancer Nanotechnology Plan 2015. National Cancer Institute. Available at http://nano.cancer.gov/about/plan/.
• Golan T, Grenader T, Ohana P, Amitay Y, Shmeeda H, La-Beck NM, Tahover E, Berger R, Gabizon AA. Pegylated liposomal mitomycin C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patients. Cancer Med 2015;4:1472-83.
• Moore DC, Moore A. Abiraterone-induced rhabdomyolysis: a case report. J Oncol Pharm Pract 2015 Dec 3. [Epub ahead of print]
• Biganzoli L, Lichtman S, Michel JP, Papamichael D, Quoix E, Walko C, Aapro M. Oral single-agent chemotherapy in older patients with solid tumours: a position paper from the International Society of Geriatric Oncology (SIOG). Eur J Cancer 2015;51:2491-500.
• Shea TC, Walko C, Chung Y, Ivanova A, Sheets J, Rao K, Gabriel D, Comeau T, Wood W, Coghill J, Armistead P, Sarantopoulos S, Serody J. Phase I/II trial of dose-escalated busulfan delivered by prolonged continuous infusion in allogeneic transplant patients. Biol Blood Marrow Transplant 2015;21:2129-35.
• Hertz DL, Snavely AC, McLeod HL, Walko CM, et al. In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles. Br J Clin Pharmacol 2015;80:1122-30.
• Ward MA, Fang G, Richards KL, Walko CM, et al. Comparative evaluation of patients newly initiating first-generation versus second-generation tyrosine kinase inhibitors for chronic myeloid leukemia and medication adherence, health services utilization, and healthcare costs. Curr Med Res Opin 2015;31:289-97.
• Dey N, Williams C, Leyland-Jones B, De P. A critical role for HER3 in Her2-amplified and non-amplified breast cancers: function of a kinase-dead RTK. Am J Transl Res 2015;7:733-50.
• Williams CB, McMahon C, Ali SM, et al. A metastatic colon adenocarcinoma harboring BRAF V600E has a durable major response to dabrafenib/trametinib and chemotherapy. Onco Targets Ther 2015;8:3561-4.

 

Invited Talks

• Ninh (Irene) La-Beck: Invited speaker. Mechanisms and barriers in nanomedicine conference. Colorado Center for Nanomedicine and Nanosafety; July 15, 2016; Breckenridge, CO.
• Casey Williams: Updates in the treatment of chemotherapy-induced nausea and vomiting. CME lectures sponsored by Educational Concept Group. Dallas, TX; Milwaukee, WI; Omaha, NE; Denver, CO; Portland, OR; Seattle, WA; and Phoenix, AZ. 2014–2015.
• Casey Williams: Precision oncology on the frontier. Osher Lifelong Learning Institute (OLLI) CE Program; February 2015; Sioux Falls, SD.

 

Introduction

The HIV PRN presented its inaugural focus session, “HIV Across the Ages,” at the 2015 Global Conference. This session focused on perinatal prevention, transmission, and management of HIV as well as HIV management in the pediatric and older adult populations.

HIV PRN members are encouraged to share their diverse clinical practices, research, education, and training experiences in order to network with other members. As a newer PRN, we hope to continue to recruit new trainees and members as well as expand education and networking opportunities. If you know other individuals (including trainees) interested in learning more about or joining the HIV PRN, please encourage them to do so!

The PRN has been advancing clinical practice, education, and research. Notable achievements are as follows.

 

Awards

• Melanie R. Nichol: Powell Center Research Scholar from the Deborah E. Powell Center for Women’s Health.

 

Grants

• Sarah Michienzi: ASHP Foundation Pharmacy Resident Practice-Based Research Grant.
• Melanie R. Nichol: “Identifying Determinants of Efficacy in Female Genital Tissues to Optimize HIV Prevention.” Funded by Deborah E. Powell Center for Women’s Health.
• Kimberly Scarsi (PI) and Kristin Darin (Co-PI): NIH, NICHD R01 (1R01HD085887): “Pharmacologic Strategies to Use the Levonorgestrel Implant in HIV-Infected Women.”

 

Publications

• Adams JL, Byrne D, Pepe R, Gray A, Baxter JD. Virological failure in two patients with HIV-1 RNA viral loads >1,000,000 copies/ml initiated on elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate. Antivir Ther 2015 Aug 26. [Epub ahead of print]
• Badowski ME, Perez SE. Clinical utility of dronabinol in the treatment of weight loss associated with HIV and AIDS [invited review]. HIV/AIDS Res Palliat Care 2016:8:37-45.
• Biagi M, Badowski M, Chiampas T, Young J, Vaughn P, Shicker L, Patel M. Administration of tenofovir disoproxil fumarate-based antiretroviral therapy in an HIV-infected patient following unilateral nephrectomy. Int J STD AIDS. 2015 Sep 16. [Epub ahead of print]
• Billedo J, Berkowitz L, Cha A. Evaluating the impact of a pharmacist-led antiretroviral stewardship program on reducing drug interactions in HIV-infected patients. J Int Assoc Provid AIDS Care 2016;15:84-8.
• Cope R, Berkowitz L, Arcebido R, Yeh JY, Trustman N, Cha A. Evaluating the effects on an interdisciplinary practice model with pharmacist collaboration on HIV patient co-morbidities. AIDS Patient Care STDS 2015;29:445-53.
• Crutchley RD, Guduru RC, Cheng AM. Evaluating the role of atazanavir/cobicistat and darunavir/cobicistat fixed-dose combinations for the treatment of HIV-1 infection. HIV/AIDS Res Palliat Care 2016;7:1-19.
• Gilbert EM, Darin KM, Scarsi KK, McLaughlin MM. Antiretroviral pharmacokinetics in pregnant women. Pharmacotherapy 2015;35:838-55.
• Parikh S, Fehintola F, Huang L, Olson A, Adedeji WA, Darin KM, Morse GD, Murphy RL, Taiwo BO, Akinyinka OO, Adewole IF, Aweeka FT, Scarsi KK. Artemether-lumefantrine exposure in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy. Antimicrob Agents Chemother 2015;59:7852-6.
• Date AD, Destache CJ. Natural polyphenols: potential in the prevention of sexually transmitted viral infections. Drug Discov Today 2015 Nov 4. [Epub ahead of print]
• Kovarova M, Council OD, Date AA, Long J, Nochii T, Belshan M, Shibata A, Vincent H, Baker CE, Thayer WO, Kraus G, Lachaud-Durand S, Williams P, Destache CJ, Garcia JV. Nanoformulations of rilpivirine for topical pericoital and systemic coital-independent administration efficiently prevent HIV transmission. PLoS Pathogen 2015;11:e1005075.
• Mandal S, Zhou Y, Shibata A, Destache CJ. Confocal fluorescence microscopy: an ultra-sensitive tool used to evaluate intracellular antiretroviral nano-drug delivery in HeLa cells. AIP Adv 2015;5:084803.
• McLaughlin MM, Skoglund E, Bergman S, Scheetz MH. Development of a pharmacy student research program at a large academic medical center. Am J Health Syst Pharm 2015;72:1885-9.
• McLaughlin MM, Skoglund EW, Ison MG. Peramivir: an intravenous neuraminidase inhibitor. Expert Opin Pharmacother 2015;16:1889-900.
• Bookstaver PB, Bland CM, Griffin B, Stover KR, Eiland LS, McLaughlin M. A review of antibiotic use in pregnancy. Pharmacotherapy 2015;35:1052-62.
• Gilbert EM, Darin KM, Scarsi KK, McLaughlin MM. Antiretroviral pharmacokinetics in pregnant women. Pharmacotherapy 2015;35:838-55.
• Rhodes NJ, O’Donnell JN, Lizza BD, McLaughlin MM, Esterly JS, Scheetz MH. Tree-based models for the prediction of mortality in gram-negative bacteremia: avoid putting the CART before the horse. Antimicrob Agents Chemother 2015 Nov 23. [Epub ahead of print]
• Calderon MM, Penzak SR, Pau AK, Kumar P, McManus M, Alfaro RM, Kovacs JA. Efavirenz but not atazanavir/ritonavir significantly reduces atovaquone concentrations in HIV-infected subjects. Clin Infect Dis 2016 Jan 20. [Epub ahead of print]
• Sawkin MT, Deppe SJ, Thelen J, Stoner, SC, Dietz CA, Rasu RS. Health literacy and medication adherence among patients treated in a free health clinic: a pilot study. Health Serv Res Manag Epidemiol 2015;2:1-7.
• Scarsi KK, Darin KM, Nakalema S, Back DJ, Byakika-Kibwika P, Else LJ, Dilly-Penchala S, Buzibye A, Cohn SE, Merry C, Lamorde M. Unintended pregnancies observed with combined use of the levonorgestrel contraceptive implant and efavirenz-based antiretroviral therapy: a three-arm pharmacokinetic evaluation over 48 weeks. Clin Infect Dis 2015 Dec 8. [Epub ahead of print]
• Scarsi KK, Eisen G, Darin KM, Meloni ST, Rawizza HE, Tchetgen Tchetgen EJ, Agbaji OO, Onwujekwe DI, Gashau W, Nkado R, Okonkwo P, Murphy RL, Kanki PJ. Superior effectiveness of zidovudine compared with tenofovir when combined with nevirapine-based antiretroviral therapy in a large Nigerian cohort. Clin Infect Dis 2016;62:512-8.
• Scarsi KK, Prinz EA, Snyder HK, Olsen KM, Zhang L, Zeng L, Gui G. Development and practice of clinical pharmacy in the United States. China Pharmacy 2015;26:3601-11.
• Bares SH, Sandkovsky US, Talmon GA, Hutchins GF, Swindells S, Scarsi KK. Dolutegravir-induced colitis in an HIV-infected patient. J Antimicrob Chemother 2016;71:281-2.
• Hernandez J, Segarra-Newnham M. Evaluation of eradication rates for macrolide-based treatment of Helicobacter pylori infection in an era of increasing resistance. Ann Pharmacother 2015;49:1265-66.

 

New ACCP Fellows

• E. Kelly Hester
• R. Chris Rathbun

 

Other Notable Achievements

• Mark Shaefer: Has changed jobs from Head of North American Medical Affairs at ViiV Healthcare to Global Medical Lead for Cabotegravir at ViiV.

 

Grants

• Ninh (Irene) La-Beck: NIH/NCI R15CA192097-01A1 ($453,173) awarded August 6, 2015, for grant titled, “Abrogating Nanoparticle-Induced Immunosuppression in Tumor Microenvironment.” (PI)
• David I. Min (PI) and Youngil Chang (Research Fellow) (Co-I): “Glycosylation Pattern of Donor-Specific Antibody as a Novel Diagnostic Marker for Antibody-Mediated Rejection in Kidney Transplant Patients” – $49,500 funded by Mendez National Institute of Transplantation, 2015–2016.

 

Publications

• Freeman CM, Woodle ES, Shi J, Alexander JW, Leggett PL, Shah SA, Paterno F, Cuffy MC, Govil A, Mogilishetty G, Alloway RR, Hanseman D, Cardi M, Diwan TS. Addressing morbid obesity as a barrier to renal transplantation with laparoscopic sleeve gastrectomy. Am J Transplant 2015;15:1360-8. Epub 2015 Feb 23.
• Krisl JC, Alloway RR, Shield AR, Govil A, Mogilishetty G, Cardi M, Diwan T, Abu Jawdeh BG, Girnita A, Witte D, Woodle ES. Acute rejection clinically defined phenotypes correlate with long-term renal allograft survival. Transplantation 2015;99:2167-73.
• Mittal T, Dedhia P, Roy-Chaudhury P, Abu Jawdeh BG, Mogilishetty G, Cuffy MC, Alloway RR, Woodle ES, Govil A. Complete remission of post-transplantation recurrence of focal segmental glomerulosclerosis with the use of adrenocorticotrophic hormone gel: case report. Transplant Proc 2015;47:2219-22.
• Revollo JY, Cuffy MC, Abu Jawdeh BG, Paterno F, Girnita A, Brailey P, Alloway RR, Woodle ES. Case report: successful living donor kidney transplantation in a highly human leukocyte antigen-sensitized recipient with a positive cytotoxic crossmatch using bortezomib-based desensitization without intravenous immunoglobulin. Transplant Proc 2015;47:2254-7.
• Revollo JY, Cuffy MC, Witte DP, Paterno F, Alloway RR, Woodle ES. Case report: hemolytic anemia following deceased donor renal transplantation associated with tranexamic acid administration for disseminated intravascular coagulation. Transplant Proc 2015;47:2239-42.
• Sadaka B, Ejaz NS, Shields AR, Cardi MA, Wadih G, Witte D, Abu Jawdeh BG, Alloway RR, Woodle ES. A Banff component scoring-based histologic assessment of bortezomib-based antibody-mediated rejection therapy. Transplantation 2015;99:1691-9.
• Shokati T, Bodenberger N, Gadpaille H, Schniedewind B, Vinks AA, Jiang W, Alloway RR, Christians U. Quantification of the immunosuppressant tacrolimus on dried blood spots using LC-MS/MS. J Vis Exp 2015;(105).
• Stegall MD, Morris RE, Alloway RR, Mannon RB. Developing new immunosuppression for the next generation of transplant recipients: the path forward. Am J Transplant 2016 Jan 5. [Epub ahead of print]
• Doligalski CT, Jennings DL. Device-related thrombosis in continuous-flow left ventricular assist device support. J Pharm Pract 2016;29:58-66.
• Doyle IC, Malhotra A. Polymer-based augmentation of immunosuppressive formulations: application of polymer technology in transplant medicine. In: Thakur VK, Thakur MK, eds. Handbook of Polymers for Pharmaceutical Technologies: Processing and Applications, Vol. 2. Hoboken, NJ: John Wiley & Sons, 2015.
• Vacha M, Gommer J, Rege A, Sanoff, S, Sudan D, Harris M. Effects of ideal versus total body weight dosage of rabbit antithymocyte globulin on outcomes of kidney transplant patients with high immunologic risk. Exp Clin Transplant 2016 Jan 8. [Epub ahead of print]
• DePalma R, Knorr JP, Navarro V. Immunology of liver transplantation. In: Cataldo D, ed. Contemporary Liver Transplantation: The Successful Liver Transplant Program. Springer International Publishing, 2015. http://link.springer.com/referenceworkentry/10.1007/978-3-319-05543-5_20-1.
• La-Beck NM, Jean GW, Huynh C, Alzghari SK, Lowe DB. Immune checkpoint inhibitors: new insights and current place in cancer therapy. Pharmacotherapy 2015;35:963-76.
• Gabizon AA, La-Beck NM. Optimizing nanoparticle delivery of chemotherapeutics. In: Cancer Nanotechnology Plan 2015. National Cancer Institute. Available at http://nano.cancer.gov/about/plan/.
• Golan T, Grenader T, Ohana P, Amitay Y, Shmeeda H, La-Beck NM, Tahover E, Berger R, Gabizon AA. Pegylated liposomal mitomycin-C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patients. Cancer Med 2015;4:1472-83.
• Lenhard JR, Brown T, Rybak MJ, Meaney CJ, Norgard NB, Bulman ZP, Brazeau D, Gill SR, Tjusi BT. Sequential evolution of vancomycin-intermediate resistance alters virulence in Staphylococcus aureus: PK/PD targets for vancomycin exposure. Antimicrob Agents Chemother 2015 Dec 28. [Epub ahead of print]
• Venuto RC, Meaney CJ, Chang S, Leca N, Consiglio JD, Wilding GE, Brazeau D, Gundroo A, Nainani N, Morse SE, Cooper LM, Tornatore KM. Association of extrarenal adverse effects of immunosuppression with sex and ABCB1 haplotypes. Medicine (Baltimore). 2015;94:e1315.
• Woodruff AE, Meaney CJ, Hansen E, Prescott GM. Azithromycin-induced, biopsy-proven acute interstitial nephritis in an adult successfully treated with low-dose corticosteroids. Pharmacotherapy 2015;35:e169-74.
• Doyle IC, Maldonado AQ, Heldenbrand S, Tichy EM, Trofe-Clark J. Non-adherence to therapy after adult solid organ transplantation: a focus on risks and mitigation strategies. Accepted for publication.
• Sawinski D, Kaur N, Ajeti A, Trofe-Clark J, Lim M, Bleicher M, Goral S, Forde KA, Bloom RD. Successful treatment of hepatitis C in renal transplant recipients with direct-acting antiviral agents. Am J Transplant 2015 Nov 25. [Epub ahead of print]

 

Presentations

• Casale J, Logan AT, Doligalski CT. Early acute kidney injury in lung transplantation is associated with significant mortality. Accepted for presentation at: International Society for Heart and Lung Transplantation Annual Meeting and Scientific Sessions; April 2016.
• Casale J, Logan AT, Doligalski CT. Early post-operative acute kidney injury in heart transplant recipients: who gets it, and does it matter? Accepted for presentation at: International Society for Heart and Lung Transplantation Annual Meeting and Scientific Sessions; April 2016.
• Doyle IC, Marcus K, Elbarbry FA, Marlow C, Fuentes D. Mini session: mapping exam questions to curricular outcomes. American Association of Colleges of Pharmacy Annual Meeting; July 2015.
• Hammad S, Shah L, Restivo M, Robbins H, Scheffert J. Outcomes associated with ganciclovir-resistant cytomegalovirus in lung transplant recipients. Accepted for presentation at: International Society for Heart and Lung Transplantation Annual Meeting and Scientific Sessions; April 2016.
• La-Beck NM. Nanomedicine and nanosafety. Invited speaker. Mechanisms and Barriers in Nanomedicine Conference; July 2016.
• Trofe-Clark J. Collaboration at its finest: a case-based approach highlighting the significance of the multi-disciplinary team – pre-transplant phase: effective pharmacologic evaluation of transplant candidates. Invited faculty member and premeeting member speaker. American Transplant Congress; June 2016.

 

Promotions

• Ian Doyle: Assistant Dean for Pharmacy Practice at Pacific University School of Pharmacy

 

Other Notable Accomplishments

The following individuals were selected as Fellows of the American Society of Transplantation 2015 (FAST):

• Barrett Crowther
• Steven Gabardi
• Nicole Pilch
• Lisa Potter
• Christin Rogers
• Lonnie Smith
• Eric Tichy
• Jennifer Trofe-Clark

 

Introduction

The ID PRN is one of the largest PRNs, with just over 2500 members, more than one-third of whom are residents and students. The ID PRN became the first PRN to add residents to the executive committee, with Sarah Tennant and Erin McCreary joining this past October. The ID PRN has four active committees (Programming, Nominations, Awards, and Publications), which are working diligently to support and encourage membership involvement through educational session development, development of new awards and recognition categories for our members, and publication of a PRN newsletter. The ID PRN continues to support research and scholarly activity, with consistent donations to the Frontiers Fund and support for members with scholarships to the Focused Investigator Training (FIT) or Mentored Research Investigator Training (MeRIT) program.

In fall/winter 2015, the ID PRN increased its social media presence by forming a Twitter account with almost 400 followers (@accpinfdprn), as well as broadcasting the 2015 ID PRN business meeting live by Periscope.

 

Promotions

• Jolie Jantz: Antimicrobial Stewardship Coordinator.

 

Awards

• Chris Frei: P3 Class Teaching Award, UT Austin College of Pharmacy.
• Chris Frei: Outstanding Faculty Member of the Year, Phi Lambda Sigma (national pharmacy leadership society), UT Austin College of Pharmacy Student Chapter UT Austin College of Pharmacy.
• Polly Jen: NJSHP (New Jersey Society of Health-System Pharmacists) Pharmacist Practitioner Award.
• Amelia Sofjan: 2016 American Association of Colleges of Pharmacy New Investigator Award.

 

Grants

• Chris Bland and Bruce Jones: “The Use of Penicillin Skin Testing as an Antimicrobial Stewardship Initiative in a Not-for-profit Community Health System.” 2016–2017. (Co-PIs)
• Chris Frei: NIH/NCATS (National Center for Advancing Translational Sciences) 5UL1 TR001120 and 8KL2 TR000118 (2013–2018): “Institute for Integration of Medicine and Science (IIMS): A Partnership to Improve Health.” Role: Program Director, Translational Science Ph.D. Program.
• Chris Frei: Establishing the Veterans Administration chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) populations and establishing cancer drug usage over a 5-year period. (Co-PI)
• Warren Rose: NIH/NIAID “Identification of Evolved Molecules That Provide Defense Against Infection in a Natural System.” (Co-I)
• Doug Slain: “Choosing Wisely in West Virginia Initiative to Reduce Avoidable Antibiotic Prescriptions in Outpatient Settings.” From: West Virginia Clinical and Translational Science Institute. (Co-I)

 

Publications

• Aitken SL, Alam MJ, Khaleduzzuman M, Walk ST, Musick WL, Pham VP, Christensen JL, Atmar RL, Xie Y, Garey KW. In the endemic setting, Clostridium difficile ribotype 027 is virulent but not hypervirulent. Infect Control Hosp Epidemiol 2015;36:1318-23.
• Aitken SL, Zhou J, Ghantoji SS, Kontoyiannis DP, Jones RB, Tam VH, Chemaly RF. Pharmacokinetics and safety of intravesicular cidofovir in allogeneic HSCT recipients. J Antimicrob Chemother 2015 Nov 26. [Epub ahead of print]
• Pham VP, Luce AM, Ruppelt SC, Wei W, Aitken SL, Musick WL, Roux RK, Garey KW. Age-stratified treatment response rates in hospitalized patients with Clostridium difficile infection treated with metronidazole. Antimicrob Agents Chemother 2015;59:6113-6.
• Beardsley JR, Jones CM, Williamson J. Pharmacist involvement in a multidisciplinary initiative to reduce sepsis-related mortality. Am J Health Syst Pharm 2016;73:143-9.
• Bland CM, Bookstaver PB. Editorial commentary: double gram-positive coverage for acute bacterial skin and skin structure infections: has the eagle landed? Clin Infect Dis 2015;61:1155-6.
• Bookstaver PB, Bland CM, Griffin B, Stover KR, Eiland LS, McLaughlin M. A review of antibiotic use in pregnancy. Pharmacotherapy 2015;35:1052-62.
• Bookstaver PB, Foster JL, Lu ZK, Mann JR, Ambrose C, Grant A, Burgess S. Hepatitis B virus seroconversion rates among health sciences students in the southeastern United States. J Am Coll Health 2016;64:69-73.
• Brigmon MM, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN. Impact of fluoroquinolone resistance in gram-negative bloodstream infections on healthcare utilization. Clin Microbiol Infect 2015;21:843-9.
• Cox C, Hashem NG, Tebbs J, Bookstaver PB, Iskersky V. Evaluation of caffeine and the development of necrotizing enterocolitis. J Neonatal Perinatal Med 2015;8:339-47.
• Cleary JD, Stover KR. Antifungal-associated cardiac drug-induced disease. Clin Infect Dis 2015;61(suppl 6):S662-8.
• Day SA, Cucci M, Droege ME, et al. Major publications in the critical care pharmacotherapy literature: January-December 2014. Am J Health Syst Pharm 2015;72:1974-85.
• Dixon B, Zhang Y, El-Beyrouty C, Bonanni S, Hess B. Bad to the bone: ceftolozane/tazobactam for osteomyelitis: two case reports. ASHP 50th Annual Midyear Clinical Meeting; December 2015.
• Kachur E, Mitchell M, El-Beyrouty C, Peahota M. Evaluation of the efficacy and safety of high dose tigecycline in 3 critically ill patients. ASHP 50th Annual Midyear Clinical Meeting December 2015.
• Cadena J, Richardson AM, Frei CR. Risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in MRSA-colonized patients discharged from a Veterans Affairs hospital. Epidemiol Infect 2015:1-5.
• Garey KW, Aitken SL, Gschwind L, Goddu S, Xie Y, Duff C, Barbut F, Shah DN, DuPont HL. Development and validation of a Clostridium difficile health-related quality-of-life questionnaire. J Clin Gastroenterol 2016 Jan 19. [Epub ahead of print]
• Gilbert EM, Darin KM, Scarsi KK, McLaughlin MM. Antiretroviral pharmacokinetics in pregnant women. Pharmacotherapy 2015;35:838-55.
• Grim SA, Layden JE, Roth P, Gallitano S, Adams W, Clark NM. Latent tuberculosis in abdominal transplant patients: a review of treatment practices and outcomes. Transplant Infect Dis 2015;17:768-77.
• Clark NM, Grim SA, Lynch JP III. Posaconazole: use in the prophylaxis and treatment of fungal infections. Semin Respir Crit Care Med 2015;36:767-85.
• Gibble AM, Gross AE, Huang AM. Examining the clinical effectiveness of non-carbapenem β-lactams for the treatment of extended-spectrum β-lactamase-producing Enterobacteriaceae. Antibiotics 2015;4:653-66.
• Dan S, Shah A, Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN. Prediction of fluoroquinolone resistance in gram-negative bloodstream infections. Antimicrob Agents Chemother 2016 Feb 1. [Epub ahead of print]
• Gross AE, Bryson ML. Oral ribavirin for the treatment of noninfluenza respiratory viral infections: a systematic review. Ann Pharmacother 2015;49:1125-35.
• Guarascio AJ, Slain D. Review of the new oral tablet and intravenous dosage forms of posaconazole. Pharmacotherapy 2015;35:208-19.
• Gubbins PO, Li C. Influence of influenza and pneumococcal vaccines on CAP outcomes among the elderly. Curr Infect Dis Rep 2015;17:49.
• Pariser JJ, Anderson BB, Pearce SM, Han Z, Rodriguez JA 3rd, Landon E, Pisano J, Smith ND, Steinberg GD. The effect of broader, directed antimicrobial prophylaxis including fungal coverage on perioperative infectious complications after radical cystectomy. Urol Oncol 2015 Nov 10.
• Jeffres MN, Narayanan PP, Shuster JE, Schramm GE. Consequences of avoiding β-lactams in patients with β-lactam allergies. J Allergy Clin Immunol 2015. [Epub in press]
• Jen SP, Zucker J, Buczynski P, et al. Medication errors with antituberculosis therapy in an inpatient, academic setting: forgotten but not gone. J Clin Pharm Ther 2016;41:54-8.
• Zucker J, Mittal J, Jen SP, et al. Impact of stewardship interventions on antiretroviral medication errors in an urban medical center: a three year, multi-phase study. Pharmacotherapy 2016. [Epub ahead of print]
• Kullar R, Sakoulas G, Deresinski S, van Hal SJ. When sepsis persists: a review of MRSA bacteraemia salvage therapy. J Antimicrob Chemother 2015 Nov 12. [Epub ahead of print]
• Kullar R, Vassallo A, Turkel S, Chopra T, Kaye KS, Dhar S. Degowning the controversies of contact precautions for methicillin-resistant Staphylococcus aureus: a review. Am J Infect Control 2016;44:97-103.
• Labreche MJ, Graber CJ, Nguyen HM. Recent updates on the role of pharmacokinetics-pharmacodynamics in antimicrobial susceptibility testing as applied to clinical practice. Clin Infect Dis 2015;61:1446-52.
• Lacy MK, Stryjewski ME, Wang W, Hardin TC, Nogid B, Luke DR, Shorr AF, Corey GR, Barriere SL. Telavancin hospital-acquired pneumonia trials: impact of gram-negative infections and inadequate gram-negative coverage on clinical efficacy and all-cause mortality. Clin Infect Dis 2015;61:S87-S93.
• Lee YR, Houngue C, Hall RG., Treatment of community-acquired pneumonia. Expert Rev Anti Infect Ther 2015;13:1109-21.
• Lee YR, McMahan D, McCall C, Perry GK. Complicated intra-abdominal infections: the old antimicrobials and the new players. Drugs 2015;75:2097-117.
• McCreary EK, Hayney MS. Adult vaccines for individuals with human immunodeficiency virus infection. J Am Pharm Assoc 2015;55:560-2.
• Nichols K, Chung EK, Knoderer CA, Dees J, Healy DP, Buenger LE, Crumby AS, Kays MB. Population pharmacokinetics and pharmacodynamics of extended-infusion piperacillin and tazobactam in critically ill children. Antimicrob Agents Chemother 2016;60:522-31.
• Peahota M, Shah B, El-Beyrouty C, Schafer J. Healthcare-associated pneumonia: who is truly at risk for multidrug resistant pathogens? Am J Health Syst Pharm 2015;72:e65-72.
• Percival KM, Brock JT, Peterson ND. Delivery of antifungal agents from bone cement. Curr Fungal Infect Rep. Available online.
• Percival KM, Valenti KM, Schmittling SE, Strader BD, Lopez RR, Bergman SJ. Impact of an antimicrobial stewardship intervention on urinary tract infection treatment in the ED. Am J Emerg Med 2015;33:1129-33.
• Reveles KR, Mortensen EM, Attridge RT, Frei CR. Comparative-effectiveness of vancomycin and linezolid as part of guideline-recommended empiric therapy for healthcare-associated pneumonia. BMC Res Notes 2015;8:450.
• Rhodes NJ, O’Donnell JN, Lizza BD, McLaughlin MM, Esterly JS, Scheetz MH. Tree-based models for the prediction of mortality in gram-negative bacteremia: avoid putting the CART before the horse. Antimicrob Agents Chemother 2015 Nov 23. [Epub ahead of print]
• Rokas KE, Johnson JW, Beardsley JR, et al. The addition of intravenous metronidazole to oral vancomycin is associated with improved mortality in critically ill patients with Clostridium difficile infection. Clin Infect Dis 2015;60:934-41.
• Berti AD, Theisen E, Sauer JD, Nonejuie P, Olson, J, Pogliano J, Sakoulas G, Nizet V, Proctor RA, Rose WE. Penicillin binding protein 1 is important in the compensatory response of Staphylococcus aureus to daptomycin-induced membrane damage and is a potential target for β-lactam-daptomycin synergy. Antimicrob Agents Chemother 2016;60:451-8.
• Shukla SK, Rose WE, Schrodi SJ. Complex host genetic susceptibility to Staphylococcus aureus infections. Trends Microbiol 2015;23:529-36.
• Hernandez J, Segarra-Newnham M. Evaluation of eradication rates for macrolide-based treatment of Helicobacter pylori infection in an era of increasing resistance. Ann Pharmacother 2015;49:1265-66.
• Shah PJ, Bergman SJ, Graham DR, Glenn S. Monitoring of outpatient parenteral antimicrobial therapy and implementation of clinical pharmacy services at a community hospital infusion unit. J Pharm Pract 2015;28:462-8.
• Slain D. Chapter 30: invasive fungal infections. In: Sutton SS, ed. McGraw-Hill’s NAPLEX Review Guide, 2nd ed. New York: McGraw-Hill, 2015.
• Slain D, Cleary JD. Isavuconazonium sulfate: a novel antifungal agent. Curr Fungal Infect Rep 2015;9(4).
• Jacobson SM, Slain D. Evaluation of ATLAS score in predicting clinical cure and recurrence of Clostridium difficile infection. Am J Health Syst Pharm 2015;72:1871-5.
• Venci DP, Slain D, Elswick BM, Sarwari AR, Ross AL, Smithmyer A, Hare JT, Briggs F. Inclusion of social media-based strategies in a health care worker influenza immunization campaign [research letter]. Am J Infect Control 2015;43:902-3.
• Stover KR, Cleary JD. Cardiac response to centrally administered echinocandin antifungals. J Pharm Pharmacol 2015;67:1279-83.
• Chastain DB, Henderson H, Stover KR. Epidemiology and management of antiretroviral-associated cardiovascular disease. Open AIDS J 2015;9:23-37.
• Tennant SJ, Burgess DR, Rybak JM, Martin CA. Utilizing Monte Carlo simulations to optimize institutional empiric antipseudomonal therapy. Antibiotics 2015;4:643-52.
• Tesh LD, Shaeer KM, Cho JC, Estrada SJ, Huang V, Bland CM, DiMondi VP, Potter AN, Hussein G, Bookstaver PB. Neisseria gonorrhoeae and fosfomycin: past, present and future. Int J Antimicrob Agents 2015;46:290-6.
• Teshome BF, Lee GC, Reveles KR, Attridge RT, Koeller J, Wang CP, Mortensen EM, Frei CR. Application of a methicillin-resistant Staphylococcus aureus risk score for community-onset pneumonia patients and outcomes with initial treatment. BMC Infect Dis 2015;15:380.
• Timbrook T, Maxam M, Bosso J. Antibiotic discontinuation rates associated with positive respiratory viral panel and low procalcitonin results in proven or suspected respiratory infections. Infect Dis Ther 2015;4:297-306.
• Wargo KA, McCreary EK, English TM. Vancomycin combined with clindamycin with the treatment of acute bacterial skin and skin-structure infections. Clin Infect Dis 2015;61:1148-54.
• Zeitler K, Joshi R. Optimize antimicrobial stewardship. Pharmacy Purchasing & Products 2015;12:18.
• Zembles TN, Thompson NE, Huppler AR, Havens PL. Development of a voriconazole clinical practice guideline at a pediatric institution. J Pharm Soc Wis 2016;19:31-3.

 

Other Notable Achievements

• Brandon Dionne: AAHIVP Certification.
• Dana Fleischman: Hospital Pharmacy Manager.
• Zhe Han: BCPS Certification.
• Brian Hughes: SIDP Antimicrobial Stewardship Certification.
• Dave Luke: National Director of MSLs at Melinta Therapeutics.
• Jessica Sobnosky: BCPS Certification.
• Lauren Tesh: Became Designated Federal Officer for the FDA, CDER, Antimicrobial Drugs Advisory Committee.

 

Introduction

Our Nephrology PRN members have been participating in teaching, scholarship, and clinical and professional service. We are proud to share the many accomplishments of our members.

 

Promotions

• Linda Awdishu: Associate Clinical Professor of Pharmacy and Medicine, UC San Diego Skaggs School of Pharmacy.
• Ruth Ann Subach: Senior Director, Clinical Operations at Trevena.
• Tran Tran: Associate Professor, Midwestern University College of Pharmacy.
• Mary Vilay: Associate Professor, University of New Mexico College of Pharmacy.

 

Awards

• Bruce Mueller: Michigan Institute for Clinical & Health Research Distinguished Clinical and Translational Research Mentor Award, 2015.
• Bruce Mueller: 65th Annual University of Wisconsin Kremers Lecturer, 2015.
• Bruce Mueller: University of Michigan Provost’s Teaching Innovation Prize (Faculty Team Lead: Burgunda Sweet), 2015.
• Ifeanyi Onor: 2015 Preceptor of the Year Award, Xavier University of Louisiana College of Pharmacy.
• Lori Wazny: Journal Article Award, Canadian Association of Nephrology Nurses and Technologists (CANNT) Journal, 2015.
• Lori Wazny: Award of Excellence, Canadian Society of Hospital Pharmacists (CSHP) Manitoba Branch, 2015.

 

Grants

• Mueller BA (PI), Gharibian KN, Lewis SJ. “Regadenoson Clearance During Hemodialysis: An In Vitro Investigation.” Astellas.
• Mueller BA (PI), Heung M. “Role of Phosphate Replacement in Patients Receiving CRRT.”
• Mueller BA (PI), Lewis SJ, Gharibian KN. “Ceftolozane/Tazobactam Clearance During Continuous Renal Replacement Therapy (CRRT): An In Vitro Investigation.” Merck.
• Mueller BA (PI), Shaw A, Chaijamorn W, Clark J.  “Time Motion Study of CRRT Solution Preparation.”
• St. Peter W: “Refining Population Management Criteria to Optimize Return on Investment of Medication Management Services in Care Transitions.” Kam-Chen Award. University of Minnesota College of Pharmacy.

 

Publications

• Awdishu L, Coates CR, Lyddane A, Tran K, Daniels CE, Lee J, El-Kareh R. The impact of real-time alerting on appropriate prescribing in kidney disease: a cluster randomized controlled trial. J Am Med Inform Assoc 2015 Nov 27. [Epub ahead of print]
• Mehta RL, Awdishu L, Davenport A, Murray PT, Macedo E, Cerda J, Chakaravarthi R, Holden AL, Goldstein SL. Phenotype standardization for drug-induced kidney disease. Kidney Int 2015;88:226-34.
• Malkinska M, El Nekidy WS, El-Masri MM, Kadri A, Donaldson C, Soong D. Outcomes associated with conventional accelerated versus once-weekly IV iron therapy in outpatients undergoing hemodialysis. Can J Hosp Pharm 2015;68:304-10.
• Flurie RW, Brophy DF. New medications to treat hyperkalemia. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey L, eds. Updates: Pharmacotherapy: A Pathophysiologic Approach, 9th ed. New York: McGraw-Hill, 2014. http://accesspharmacy.mhmedical.com/updatesContent.aspx?bookid=536&Sectionid=98653266. Accessed February 15, 2016.
• Flurie RW, Gonzales JP, Tata AL, Millstein LS, Gulati M. Hospital delirium treatment: Continuation of antipsychotic therapy from ICU to discharge. Am J Health Syst Pharm. 2015;72:S133-S139.
• Foote EF, Clarke V, Szarek JL, Waters SK, Walline V, Shea D, Goss S, Farrell M, Easton D, Dunleavy E, Arscott K. Development and evaluation of a regional, large-scale interprofessional collaborative care summit. J Allied Health 2015;44:e23-e28.
• Hudson JQ, Wazny LD. Chronic kidney disease. In: DiPiro JT, Talbert RL, Yee GC, et al., eds. Pharmacotherapy: A Pathophysiologic Approach, 10th ed. New York: McGraw Hill. In press.
• Lenhard JR, Brown T, Rybak MJ, Meaney CJ, Norgard NB, Bulman ZP, Brazeau D, Gill SR, Tjusi BT. Sequential evolution of vancomycin-intermediate resistance alters virulence in Staphylococcus aureus: PK/PD targets for vancomycin exposure. Antimicrob Agents Chemother 2015 Dec 28. [Epub ahead of print]
• Venuto RC, Meaney CJ, Brazeau DB, Consiglio J, Wilding G, Tornatore KM. Association of extrarenal adverse effects of immunosuppression with sex and ABCB1 haplotypes. Medicine 2015;94:e1315.
• Woodruff AE, Meaney CJ, Hansen E, Prescott GM. Biopsy-confirmed azithromycin-induced acute interstitial nephritis successfully treated with low dose corticosteroids. Pharmacotherapy 2015;35:e169-e174.
• Jamal JA, Mueller BA, Choi GYS, Lipman J, Roberts JA. How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy? Diagn Microbiol Infect Dis 2015;82:92-103.
• Lewis SJ, Switaj L, Mueller BA. Tedizolid adsorption and transmembrane clearance during in vitro continuous renal replacement therapy (CRRT). Blood Purif 2015;40:66-71.
• Mei JP, Ali-Moghaddam, A, Mueller BA. Survey of pharmacists’ antibiotic dosing recommendations for sustained low-efficiency dialysis. Int J Clin Pharm 2015 Oct 24. [Epub ahead of print]
• Nguyen T. Keeping up with safety warnings of oral antidiabetic drugs. J Nurse Pract 2016;12:61-2.
• Nguyen T, Liu X, Patel P. Ready for oral fecal microbiota pill in clinical practice? J Nurse Pract 2015;11:839-40.
• Nguyen T, Sin B. A case of an older adult patient and drugs associated with serotonin syndrome. Consult Pharm 2015;30:455-8.
• Stirling DL, Onor IO, Sarpong DF, Rapp KI, Crawford LD. Prescribing patterns of metformin in high-risk prediabetic patients. J La State Med Soc 2015;167:257-63.
• Pierce D. The use of alteplase for clearing peritoneal dialysis catheter occlusion. Hosp Pharm 2016. [Accepted for publication]
• Pierce DA, Russell G, Pirkle JL Jr. Incidence of hypoglycemia in patients with low eGFR treated with insulin and dextrose for Hyperkalemia. Ann Pharmacother 2015;19:1322-6.
• Viscusi ER, Webster L, Kuss M, Daniels S, Bolgnese JA, Zuckerman S, Soergel DG, Subach RA, Cook E, Skobieranda F. A randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute pain. Pain 2016;157:264-72.
• Hui-Yuen J, Tran TH, Taylor J, Truong K, Li X, Bermudez L, Starr A, Eichenfield A, Imundo L, Askanase A. Use of glucuronidated mycophenolic acid levels for therapeutic monitoring in pediatric lupus nephritis patients. J Clin Rheum 2016. Accepted for publication.
• Wazny LD, Davis CJ, Ariano R. Acid-base disorders. In: Tisdale JE, Miller DA, eds. Drug-Induced Diseases: Prevention, Detection, and Management, 3rd ed. Bethesda, MD: American Society of Health-System Pharmacists. In press.
• Wazny LD, Orsulak C, Nadurak S, Tangri N. The efficacy and safety of megestrol acetate in protein energy wasting due to chronic kidney disease: a systematic review. J Ren Nutr Jan 5. [Epub ahead of print]

 

Other Notable Achievements

• Tim Nguyen: Serves as Editor of the Prescription Pad Department for Journal for Nurse Practitioners.
• Wendy St. Peter: Appointed December 2015 to the Board of Directors, Kidney Health Initiative for a 3-year term.
• Wendy St. Peter: Appointed to the Kidney Care Quality Alliance Feasibility/Testing Workgroup to develop specifications for medication management quality measures for dialysis facilities in the United States (fall 2015).
• Wendy St. Peter: Selected to participate as a member of a Technical Expert Panel (TEP) for an evidence synthesis of “Metformin Use in Patients with Contraindications.” This review was commissioned by the Department of Veterans Affairs, Health Services Research and Development (fall 2015).
• Lori Wazny: Appointed as a pharmacist member of the Kidney Foundation of Canada National Programs and Public Policy Committee (2016).

 

Other

• Bruce Mueller: Susan Lewis, Katherine Gharibian, Alex Shaw, and Weerachai Chaijamorn are completing research fellowships under the mentorship of Dr. Mueller.

 

Introduction

The Pain and Palliative Care PRN has endorsed the “Statement of Consensus on the Proper Utilization of Urine Testing in Identifying and Treating Substance Use Disorders.” This consensus guideline was developed by a diverse group of experienced addiction treatment professionals, with support from the Center for Lawful Access and Abuse Deterrence (CLAAD). This statement, intended as a resource for clinicians in any health care practice area, documents the clinical consensus in an area of medicine for which no clinical consensus otherwise exists. The document was approved by a favorable vote of the PRN members.

 

Promotions/Appointments

• Stephanie Abel: Palliative Medicine Clinical Pharmacy Specialist at the Ohio State University Wexner Medical Center – James Cancer Hospital.
• Mary Lynn McPherson: Executive Director, Advanced Post-Graduate Education in Palliative Care.
• Victoria Tutag-Lehr: Wayne State University Investigational Review Board-Scientist M1 Member September 2015–2017; Wayne State University Investigational Review Board-Scientist M4-Alternate September 2015–2017; State of Michigan Department of Community Health Pharmacy & Therapeutics Committee Chair 2015–2017.

 

Awards

• Jeffrey Bratberg: 2016 Generation Rx Award of Excellence (national).

 

Publications

• Cimino NM, Lockman K, McPherson ML. Safe and effective use of methadone. Pract Pain Manage 2015;42-9.
• Cimino NM, McPherson ML. The pharmacist’s role in advancing opioid safety: preventing and treating opioid overdose. Pharmacy Times 2015;75-81.
• Rennick A, Atkinson T, Cimino NM, Strassels SA, McPherson ML, Fudin J. Variability in opioid equivalence calculations. Pain Med. [Published online ahead of print, September 2015]

• Fudin J, Pham TC. Dodging elusive and miscalculated opioid risks. PainWeek J 2015:56-63.
• Fudin J. New Naloxone Technologies to Reduce Opioid Overdose Fatalities. Medscape. July 31, 2015. Available at www.medscape.org/viewarticle/844947.
• Fudin J. The economics of opioids: abuse, REMS, and treatment benefits. Part 3 of continuing education module – use of opioid analgesics in managed care pactice: challenges, controversies, REMS, and optimizing patient management for your review. 2015;21:S165-S196.
• Fudin J, Pham T, Pratt J. Abuse Deterrent Formulations: Clinical Applications and Utility in Chronic Pain. Postgraduate Healthcare Education, LLC (“PHE”) Continuing Education.
• Fudin J, Pratt J, Raouf M. Are You Kidding Me? Guest blog article. Posted September 18, 2015. http://paindr.com/are-you-kidding-me/.
• Fudin J, Pratt P, Brooks A, Kominek C, Pham T. Screening tools when using opioids for chronic pain. In: American Society of Addiction Medicine Pain and Addiction Manual. Oxford: Oxford Press.
• Fudin J, Pratt Cleary J, Raouf M. Risk Tool Helps Pharmacists Qualify Patients for Take-Home Naloxone. [Published online 12/18/2015]. www.pharmacytimes.com/contributor/jeffrey-fudin/2015/12/risk-tool-helps-pharmacists-qualify-patients-for-take-home-naloxone.
• Ahmed N, Horlacher RJ, Fudin J. Opioid withdrawal: a new look at medication options. Pract Pain Manage 2015;15:58-66.
• Argoff CE, Brennan MJ, Camilleri M, Davies A, Fudin J, Galluzzi KE, Gudin J, Lembo A, Stanos SP, Webster LR. Consensus recommendations on initiating prescription therapies for opioid‐induced constipation. Pain Med 2015;16:2324-37.
• Brooks A, Kiminek C, Pham T, Fudin J. Exploring the use of chronic opioid therapy for chronic pain: when, how, and for whom? Med Clin 2015;100:81-102.
• Chambers J, Gleason RM, Kirsh KL, Twillman R, Webster L, Berner J, Fudin J, Passik SD. An online survey of patients’ experiences since the rescheduling of hydrocodone: the first 100 days. Pain Med 2015. In press.
• Gudin J, Fudin J, Laitman A, Kominek C. Opioid-Induced Constipation: new and emerging therapies. Pract Pain Manage 2015;15:38-45.
• Gudin J, Fudin J, Nalamachu S. Levorphanol use: past, present and future. Postgraduate Med 2016;128:46-53.
• Linares O, Michel T, Fudin J, Boston RC, Daly AM. Letter to the editor in Pain Physician. Integrating clinical pharmacokinetics, pharmacogenetics, and quantitative cytochrome P450 Linares OA, Fudin J, Daly-Linares A, Schiesser WE, Boston RC. Methadone recycling sustains drug reservoir in tissue. J Pain Palliat Care Pharmacother 2015:261-71.
• Linares OA, Schiesser WE, Fudin J, Pham TC, Bettinger JJ, Mathew RO, Daly-Linares A. In silico ordinary differential equation/partial differential equation hemodialysis model estimates methadone removal during dialysis. J Pain Res 2015;8:417-29.
• Pham TC, Fudin J, Raffa RB. Is levorphanol a better option than methadone? Pain Med 2015:1673-9.
• Schneider J, Fudin J. Should I discharge a patient on Percocet (oxycodone/acetaminophen) for chronic back pain with unexpected oxymorphone Q detected in her urine drug screen? Pract Pain Manage 2015;15:16-7.
• Pawasauskas J. Opioid rotation: a case report using methadone in spinal cord injury. J Opioid Manage 2015;11:443-8.
• Pratt Cleary J: RIOSORD response to 2015 highlights in pain. Submitted for publication.
• Dunleavy K, Kava K, Goldberg A, Malek M, Talley SA, Tutag-Lehr V, Hildreth JA. Comparative effectiveness of Pilates and Yoga group exercise for chronic mechanical neck pain. Physiotherapy 2015 Aug 13.
• Winans ARM, Pawasauskas J, Sera L. Symptom management overview: opioid-induced constipation. J Hematol Oncol Pharm 2015;5:2-5.

 

Presentations

• Fudin J. Two lectures: Understanding and interpreting unexpected urine drug tests and naloxone: access, pharmacology, practicality, and politics. As part of Day Long Opioid Symposium. Controversies in Pain Management Opioids: Misconceptions in Pain Management. Presented at: Quillen College of Medicine at Millennium Center; November 13, 2013; Johnson City, TN.
• Fudin J. Day Long Opioid Symposium. Presented at: New Jersey Society of Oral and Maxillofacial Surgeons at Hotel Woodbridge MetroPark; November 4, 2015; Iselin, NJ.
• Fudin J. Two lectures: 1. Dodging elusive and miscalculated opioid risks. 2. Non-opioid analgesics: anticonvulsants, antidepressants, and skeletal muscle relaxants. Presented at: PAINWeekEnd 2015 at Baltimore Marriott Waterfront Hotel; October 24, 2015; Baltimore, MD.
• Fudin J. Pain and Palliative Care PRN Focus Session: best practices in prevention and treatment of opioid overdose. Identifying patients at risk for serious, unintended opioid-related adverse events. Presented at: 2015 ACCP Global Conference on Clinical Pharmacy; October 20, 2015; San Francisco, CA.
• Fudin J. Two lectures: 1. Dodging elusive and miscalculated opioid risks. 2. Non-opioid analgesics: anticonvulsants, antidepressants, and skeletal muscle relaxants. Presented at: PAINWeekEnd 2015 at Hilton Woodcliff; October 3, 2015; Woodcliff Lake, NJ.
• Fudin J. Case studies in pain management: avoiding medical errors in prescribing appropriate analgesia. Albany Medical College’s Current Topics in Primary Care and Neurology. Update for the Primary Care Practitioner. Presented at: Conference Center at Lake Placid; September 19, 2015; Lake Placid, NY.
• Fudin J. PAINWeek 2015 at the Cosmopolitan Hotel; Las Vegas, NV:
  • September 12, 2015 – Could levorphanol levitate above methadone misadventure? (with Drs. Courtney Kominek and Abigail Brooks)
  • September 11, 2015 – Naloxone kudos vs kinetics: a debate on emergency response and comparative routes of administration (IN, IM, Auto-IM) (with Drs. Courtney Kominek and Abigail Brooks).
  • September 10, 2015 – Fudin vs Gudin: the gloves come off (with Dr. Jeffrey Gudin).
  • September 8, 2015 – State dosage thresholds and their potential impacts on pain and overdose prevention (with Dr. Stephen Zielger).
  • Fudin J, Argoff C, Camilleri M, Snodgrass B. Recommendations on initiating prescription therapies for opioid-induced constipation. American Academy of Pain Medicine Webinar Parts I and II; January 13 and 21, 2016.
  • Cleary JH, Raouf M, Nguyen U, Carpenter MR, Fudin J. Automated software platform to assess pre-validated risk for opioid-induced respiratory depression to qualify patients for in-home naloxone (Poster: 394). American Society of Health-System Pharmacists (ASHP) 2015 Midyear Clinical Meeting and Exhibition; New Orleans, LA.
  • Leung N, Pawasauskas J, Kelly M. Liposomal bupivacaine in total knee arthroplasty. Poster presented at: American Society of Health-System Pharmacy Midyear Meeting; 2015; New Orleans, LA.

• Pratt J, Raouf M, Carpenter M, Fudin J. Risk analysis of potential opioid-induced respiratory depression by RIOSORD to qualify veteran patients and their caregivers for naloxone auto-injectors and risk mitigation. PAINWeek; September 2015; Las Vegas, NV.
• Pratt Cleary JP, Raouf M, Nguyen U, Carpenter C, Fudin J. Automated software platform to assess pre-validated risk for opioid-induced respiratory depression to qualify patients for in-home naloxone. American Society of Health-System Pharmacists; December 2015; New Orleans, LA.
• Tutag-Lehr V. Appropriate opioid use and abuse risk assessment. Invited presentation at: Michigan Pharmacist Association Annual Meeting; February 27, 2016; Detroit, MI.
• Tutag-Lehr V, Divine G, Pitts D, McElmurry S, Burghardt K. Psychoactive medication use in youth. Poster presented at: 2015 Eugene Applebaum College of Pharmacy and Health Sciences 12th Annual Research Forum; November 4, 2015; Detroit, MI.

 

Peer Review Activities

• Fudin J. August 2015 to present: Editorial Board, Journal of Pharmacy Practice (JPP) in the area of Pain Management.

 

Introduction

The Pediatrics PRN continues to develop programs and resources for members. We currently have 1184 members, 541 of whom are students, residents, or fellows. This is a continued increase from last year’s record growth. Our committee work has been phenomenal for the past 6 months, and we are particularly excited to announce our new initiatives.

The Research Committee, under the guidance of Bob John and the addition of Vice Chair Hanna Phan, is beginning new initiatives in addition to the PBRN study, including developing an annual review article submitted to Pharmacotherapy to assist members with their clinical practices. The committee is also developing formal feedback for residents and students presenting posters at the 2016 ACCP Annual Meeting in Hollywood, Florida, as well as supporting member research through poster rounds. To expand on a long-term goal of professional development with research design and execution, the committee is identifying resources within ACCP to assist practitioners at every level. The PBRN study is still going through the IRB process, and we will engage the PRN when the study is ready for enrollment sites.

The Education Committee has been working toward a great session for the 2016 Annual Meeting and is making progress to establish a spring journal club program. This new program will allow a platform for residents and practitioners to review up-to-date and relevant literature. This is an exciting advancement in the provision of additional programming for our members.

The Nominations Committee is establishing timelines for officer nominations for this upcoming spring. A call for nominations will be announced in March 2016. The committee is also working with the Pediatric PRN officers to establish new awards recognizing the accomplishments of some of our outstanding members. These new awards and their selection process will be announced later.

One of our most visible committees, Social Media, has been working hard to increase activity on several venues, including Twitter. Be sure to get all the latest practice and PRN updates by following us on Facebook and Twitter! Have feedback for Facebook? Contact Chephra McKee (TTUHSC), who has been appointed vice chair of the committee and taken over many of the Facebook posting responsibilities. Also, watch for our new webpage.

Our Travel Award Committee is transitioning to different leadership, with Elizabeth Farrington as our new chair. We also welcome former award recipient Lola Afolabi as our new vice chair. This committee is actively engaged in promoting and selecting travel awards for students and residents to attend the Annual Meeting. Please consider supporting these efforts by encouraging your students and residents to apply.

We are extremely excited about the continued growth and progress of our PRN during the past year, and with your efforts, we will continue to provide and enhance the benefits to members.

 

Promotions

• Collin Hovinga: Director of Research Seton Healthcare Family Hospitals.

 

Grants

• Collin Hovinga: “Patient, Family and Healthcare Provider Prospective on the Care of Hydrocephalus: A Multi-model Study.” Inaugural Hydrocephalus Research Grant from HydroAngels of America Foundation. Award amount: $30,000.
• Hanna Phan: “Feasibility of a Mobile Medication Plan Application in Cystic Fibrosis Patient Care.” Success with Therapies Research Consortium, Cystic Fibrosis Foundation Pilot Grant. Award Amount: $815,000. (PI)

 

Publications

• Cox C, Hashem NG, Tebbs J, Bookstaver PB, Iskersky V. Evaluation of caffeine and the development of necrotizing enterocolitis. J Neonatal Perinatal Med 2015;8:339-47.
• Benefield EC, Hagemann TM, Allen HC, Farmer KC, Burton ME, Chavez-Bueno S, Johnson PN. Vancomycin dosing and pharmacokinetics in post-operative pediatric cardiothoracic surgery patients. J Pediatr Pharmacol Ther 2016;21:66-74.
• Schwartz M, Wrobel J, Huntley J, Zeilmann C. Protocol versus non-protocol dosing of vancomycin in neonates: a single-center evaluation of steady state trough levels. Am J Perinatol. [Online publication February 10, 2016]
• Boucher EA, Burke MM, Johnson PN, Klein KC, Miller JL. Minimum requirements for core competency in pediatric pharmacy practice. J Pediatr Pharmacol Ther 2015;20:458-61.
• LaRochelle JM. Book Review. Sandra Benavides, Hanna Phan, Milap Nahata. Pediatric Pharmacotherapy Self-Assessment. Curr Pharm Teach Learn 2016;8:139-40.
• LaRochelle JM, Desselle B. Critical care pharmacotherapy: description of an innovative pediatric residency elective experience utilizing clinical pharmacy faculty as preceptor. Crit Care Shock 2015;18:52-4.
• Matson KL, Shaffer CL, Beck GL, Simonsen KA. A multicenter assessment of serum vancomycin trough concentrations and the association with standard initial vancomycin dosing and nephrotoxicity in children. Pharmacotherapy 2015;35:337-43.
• Capino AC, Miller JL, Hughes KM, Miller MJ, Johnson PN. Caregiver perception, self-efficacy, and knowledge of methadone tapers for children with iatrogenic opioid abstinence syndrome. J Pharm Technol 2015;1-12.
• Golding CL, Miller JL, Gessouroun MR, Johnson PN. Ketamine continuous infusions in critically ill children. Ann Pharmacother 2016;50:234-41.
• Thomas AN, Miller JL, Couloures K, Johnson PN. Non-intravenous sedatives and analgesics for procedural sedation for imaging procedures in pediatric patients. J Pediatr Pharmacol Ther 2015;20:418-30.
• Parrish RH II. Positioning a pediatric compounded non-sterile product electronic repository (pCNPeRx) within the health information technology infrastructure. Pharmacy (Special Issue – Pharmacy Paediatrics) 2016;4:Article 2. Available at www.mdpi.com/2226-4787/4/1/2.
• Bhatt-Mehta V, MacArthur RB, Löbenberg R, Cies JJ, Cernak I, Parrish II RH. An algorithm that identifies compounded non-sterile products that can be formulated on a commercial scale or imported to promote safer medication use in children. Pharmacy (Special Issue – Pharmacy Paediatrics) 2015;3:284-94. Available at www.mdpi.com/2226-4787/3/4/284.
• Phan H, Brown MA. Fluticasone furoate for the treatment of childhood asthma. Expert Rev Respir Med 2015;9:391-404.
• Mueller EW, Bishop JR, Kanaan AO, Kiser TH, Phan H, Yang KY. Research fellowship programs as a pathway for training independent clinical pharmacy scientists. Pharmacotherapy 2015;35:e13-9.
• So TY. Probiotics – what do parents need to know? Pediatr Parents 2015;30:17-8.
• Badik J, Chen J, Letvak K, So TY. Hypersensitivity reaction to insulin glargine and insulin detemir in a pediatric patient: a case report. J Pediatr Pharmacol Ther 2016;21:85-91.
• Binz J, Adler C, So TY. The risk of musculoskeletal adverse events with fluoroquinolones in children – what is the verdict now? Clin Pediatr (Phila) 2016;55:107-10.
• Lawuyi B, Basham J, So TY. The use of penicillin for the prevention of pneumococcal infection in pediatric patients with sickle cell disease. J Pediatr Sci 2015;7:e246.
• Von Vajna E, Alam R, So TY. Current clinical trials on the use of direct oral anticoagulants in the pediatric population. Cardiol Ther 2016. [Epub ahead of print]

 

Other Notable Achievements

• Sandra Benavides and Richard Parrish: Were invited guest editors for a special issue called “Pharmacy Paediatrics” in the international, online, open access journal, Pharmacy (ISSN 2226-4787), at www.mdpi.com/journal/pharmacy/special_issues/pharmacy-paediatrics.
• Joseph M. LaRochelle: Completed a 2-year fellowship in Health Professions Education.

 

BCPPS Certification (note: this list includes only members who provided information):

• Megan Allen
• Gabriella Blyumin
• Deborah Bondi
• Brian Brown
• Christina Cox
• Joseph LaRochelle
• Bernard Lee
• Kelly Matson
• Amanda Memken
• Mary Soliman
• Jena Valdes

 

Presentations

• Richard Parrish: Clinical practice innovation: use of productivity dashboards in electronic health record systems to direct clinical workflow. Invited speaker. Clinical Administration PRN Focus Session, American College of Clinical Pharmacy Annual Meeting; October 19, 2015; San Francisco, CA.
• Richard Parrish: Development of a surgery pharmacists’ community of practice in Alberta: combining technology with tacit knowledge. Invited speaker. Provincial Pharmacy Senior Leadership Team meeting, Alberta Health Services; February 4, 2016; Edmonton, Alberta, Canada.
• Ginther M, Ginther S, Chan A, Parrish R. Development of a surgery pharmacists’ community of practice in Alberta: combining technology with tacit knowledge. Poster presented at: ACCP Global Conference on Clinical Pharmacy; October 19, 2015; San Francisco, CA. Pharmacotherapy 2015;35:e245.

 

Introduction

The Perioperative Care PRN is soliciting members to join our research efforts through the PRN’s newly launched Research and Publications Committee. To express your interest in practice-based research, a three-step process is suggested: (1) join and/or chair our Research and Publications Committee, (2) join the PBRN at www.accpri.org/pbrn/registration.aspx, and (3) apply for the Mentored Research Investigator Training (MeRIT) program at www.accpri.org/merit/. Applicants for this committee chair position are encouraged to contact PRN Chair Stacey Moultrie for more information.

The Education Committee has been working with the Pain and Palliative Care PRN to create the 2016 PRN focus session for the 2016 Annual Meeting in Hollywood, Florida, on clinical pearls related to multimodal pain management in perioperative care.

 

Presentations

• Richard Parrish: Clinical practice innovation: use of productivity dashboards in electronic health record systems to direct clinical workflow. Invited speaker. Clinical Administration PRN Focus Session, American College of Clinical Pharmacy Annual Meeting; October 19, 2015; San Francisco, CA.
• Richard Parrish: Development of a surgery pharmacists’ community of practice in Alberta: combining technology with tacit knowledge. Invited speaker. Provincial Pharmacy Senior Leadership Team Meeting, Alberta Health Services; February 4, 2016; Edmonton, Alberta, Canada.
• April Smith: “Understanding the Use of Obesity Medications: When, Why and How; VTE Prophylaxis Strategies; Weight Loss Medications in a Post-op Bariatric Surgery Patient; and Integrated Health Pharmacology Course (Moderator & Course Developer). Invited faculty. Obesity Week (combined annual meeting of the Obesity Society and the American Society for Metabolic & Bariatric Surgery); November 3, 2015; Los Angeles, CA.

 

Poster Presentations

• Ginther M, Ginther S, Chan A, Parrish R. Development of a surgery pharmacists’ community of practice in Alberta: combining technology with tacit knowledge. Presented at: ACCP Global Conference on Clinical Pharmacy; October 19, 2015; San Francisco, CA. Pharmacotherapy 2015;35:e245.

 

Publications

• Gaviola ML, McMillian W, Ames SE, Endicott JA, Alston WK. A retrospective study on the protective effects of topical vancomycin in patients undergoing multilevel spinal fusion. Pharmacotherapy 2016;36:19-25.

• Parrish II RH. Positioning a pediatric compounded non-sterile product electronic repository (pCNPeRx) within the health information technology infrastructure. Pharmacy (Special Issue – Pharmacy Paediatrics) 2016;4:Article 2. Available at www.mdpi.com/2226-4787/4/1/2.
• Bhatt-Mehta V, MacArthur RB, Löbenberg R, Cies JJ, Cernak I, Parrish II RH. An algorithm that identifies compounded non-sterile products that can be formulated on a commercial scale or imported to promote safer medication use in children. Pharmacy (Special Issue – Pharmacy Paediatrics) 2015;3:284-94. Available at www.mdpi.com/2226-4787/3/4/284.

 

Other Notable Achievements

• Sandra Benavides and Richard Parrish were invited guest editors for a special issue called “Pharmacy Paediatrics” in the international, online, open access journal, Pharmacy (ISSN 2226-4787), at www.mdpi.com/journal/pharmacy/special_issues/pharmacy-paediatrics

 

Promotions

• David R. Luke: Joined Melinta Therapeutics as the National Director responsible for building a team of Regional Medical Affairs Managers by the end of 2016.
• Kay Uttech: Senior Director of Business Operations at Baxalta.
• James Wall (Pharm.D. Candidate 2016): Appointed to Rutgers Pharmaceutical Industry Fellow in Clinical Operations – Oncology, based at Genentech in South San Francisco.

 

Publications

• Evens RP. Pharma success in product development – does biotechnology change the paradigm in product development and attrition. AAPSJ 2016;18:281-5.

 

Presentations

• Short WR, Albano JD, Cook TS, Gee C, Scheuerle AE, Tilson HH, Baugh B, Schaible D, Pecini R, Hadacek MB, Villadiego S, Brown K. Darunavir-containing antiretroviral regimens in pregnancy: findings from the Antiretroviral Pregnancy Registry. Poster PE8/11. Presented at: 15th European AIDS Conference (EACS); October 21–24, 2015; Barcelona, Spain.

 

Notable Member Achievements

Awards

• Mary Ensom and coauthors (Wang EHZ, Bolt JL, Decarie D, Semchuk W): 2015 Canadian Society of Hospital Pharmacists – BC Branch Publication Award (category: Original Research Article) for: A Study of Dabigatran Stability in 3 Clinically Relevant Environments: Manufacturer’s Blister Pack, Unit-Dose Packaging, and Community Pharmacy Blister Pack. Can J Hosp Pharm 2015;68:16-21.
• Mary Ensom and coauthors (Kyle Collins, Dan Rainkie, and Roxane Carr): 2016 Canadian Society of Hospital Pharmacists Pharmacotherapy Best Practice Award for the project “Assessment of Pediatric Vancomycin Empiric Dosing.”

 

Editorship

• Varsha Bhatt-Mehta: Associate Editor of the AAPS Open journal. An official open-access journal of the American Association of Pharmaceutical Sciences.

 

Publications

• Birdwell KA, Decker B, Barbarino JM, Peterson JF, Stein CM, Sadee W, Wang D, Vinks AA, He Y, Swen JJ, Leeder JS, van Schaik R, Thummel KE, Klein TE, Caudle KE, MacPhee I. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing. Clin Pharmacol Ther 2015;98:19-24.
• Gammal RS, Court MH, Haidar CE, Iwuchukwu OF, Gaur AH, Alvarellos M, Guillemette C, Lennox JL, Whirl-Carrillo M, Brummel S, Ratain MJ, Klein TE, Schackman BR, Caudle KE, Haas DW. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for UGT1A1 and atazanavir prescribing. Clin Pharmacol Ther 2015 Sep 29.
• Hicks JK, Bishop JR, Sangkuhl K, Muller DJ, Ji Y, Leckband SG, Leeder JS, Graham RL, Chiulli DL, A LL, Skaar TC, Scott SA, Stingl JC, Klein TE, Caudle KE, Gaedigk A. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors. Clin Pharmacol Ther 2015;98:127-34.
• Kalman LV, Agúndez JA, Appell ML, Black JL, Bell GC, Boukouvala S, Bruckner C, Bruford E, Bruckner C, Caudle K, et al.. Pharmacogenetic allele nomenclature: international workgroup recommendations for test result reporting. Clin Pharmacol Ther 2015 Oct 19.
• Saito Y, Stamp LK, Caudle KE, Hershfield MS, McDonagh EM, Callaghan JT, Tassaneeyakul W, Mushiroda T, Kamatani N, Goldspiel BR, Phillips EJ, Klein TE, Lee M. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update. Clin Pharmacol Ther 2016;99:36-7.
• Ensom MHH, Decarie D. Stability of extemporaneously compounded levetiracetam in glass and plastic bottles and plastic syringes. Can J Hosp Pharm 2015;68:346-8.
• Ensom MHH, Decarie D, Lingertat-Walsh K. Stability of extemporaneously compounded naproxen 25 mg/mL suspension in glass and plastic bottles and plastic syringes. Can J Hosp Pharm 2015;68:289-91.
• Elewa H, El-Mekaty E, El-Bardissy A, Ensom MHH, Wilby KJ. Therapeutic drug monitoring of voriconazole in the management of invasive fungal infections: a critical review. Clin Pharmacokinet 2015;54:1223-35.
• Kendrick JG, Carr RR, Ensom MHH. Pediatric obesity: pharmacokinetics and implications for drug dosing. Clin Ther 2015;37:1897-923.
• MacKenzie M, Zed PJ, Ensom MHH. Opioid pharmacokinetics-pharmacodynamics: clinical implications in acute pain management in trauma. Ann Pharmacother 2016 Jan 6. [Online first]
• Wilby KJ, Shabana S, Ensom MHH, Marra F. A critical review of the current evidence for measuring drug concentrations of first-line agents used to treat tuberculosis in children. Clin Pharmacokinet 2016;55:17-31.
• Kiang TKL, Ensom MHH. A qualitative review on the pharmacokinetics of antibiotics in saliva: implications on clinical pharmacokinetic monitoring in humans. Clin Pharmacokinet 2015 Sep 7. [Epub ahead of print]
• Kiang TKL, Wilby KJ, Ensom MHH. A comprehensive, critical review on the clinical pharmacokinetics, pharmacodynamics, and clinical trials of the novel 5th-generation cephalosporin, ceftaroline. Clin Pharmacokinet 2015;54:915-31.

 

Presentations

• Kelly E. Caudle: The Clinical Pharmacogenetics Implementation Consortium (CPIC): From evidence to clinical practice. Presented at: St. Jude Children’s Research Hospital (Clinical Pharmacists CEU accredited); January 2016.
• Kelly E. Caudle: The Clinical Pharmacogenetics Implementation Consortium (CPIC) update and term standardization project. Presented at: PGRN’s RIP seminar. January 2016.
• Kelly E. Caudle: Building personalized dosing into clinical decision support. Presented at: International Pharmaceutical Federation (FIP) 2015 Annual Meeting; September 2015.
• Kelly E. Caudle: Incorporating pharmacogenetics into clinical practice and the electronic health record. Presented at: Congreso Latinoamericano de Farmacogenomica y Medicina Personalizada; March 2015.
• Kelly E. Caudle: Clinical practices guidelines for pharmacogenomics in Latin America. Presented at: Congreso Latinoamericano de Farmacogenomica y Medicina Personalizada; March 2015.

 

Other Notable Achievements

• Keith Moore: Appointed to the University of Cincinnati Technology Commercialization Accelerator Committee (2016).

 

Introduction

The Women’s Health PRN is proud to introduce two new positions—our student liaisons! Because about 50% of our membership consists of students/residents, the PRN created these positions to help facilitate activities and content for students/residents. This also shows us the strong desire of pharmacy students to learn about women’s health, and we want to help meet that need. Ana Simonyan (St. Louis) and Audra Wilson (Regis) will be providing content for our Facebook page, website, and newsletter. They will also help create opportunities for networking within the PRN.

 

Promotions

• Alicia Forinash: Professor, St. Louis College of Pharmacy (2015).
• Brooke Griffin: Professor, Midwestern University Chicago College of Pharmacy (2015).

 

Publications

• Bhakta J, Bainbridge J, Borgelt LM. Teratogenic medications and concurrent contraceptive use in women of childbearing ability with epilepsy. Epilepsy Behav 2015;52:212-7.
• Rhyne DN, Anderson SL, Gedde M, Borgelt LM. The effect of medical marijuana on migraine headache frequency in an adult population. Pharmacotherapy 2016 Jan 9. [Epub ahead of print]
• Bookstaver PB, Bland CM, Griffin B, Stover KR, Eiland LS, McLaughlin M. A review of antibiotic use in pregnancy. Pharmacotherapy 2015;35:1052-62.
• Rafie S, Kelly S, Gray EK, Wong M, Gibbs S, Harper CC. Provider opinions regarding expanding access to hormonal contraception in pharmacies. Womens Health Issues. [Epub ahead of print]

 

Other Notable Achievements

• Sally Rafie: President-Elect of the San Diego County Pharmacists Association.

 

Other

• Sally Rafie: PRN project: Development and approval of Women’s Health PRN Awards.